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GLOSSARY OF OBSTETRIC TERMS 
Amniocentesis: Needling of the uterine cavity during pregnancy through the skin and the 
uterus, to obtain amniotic fluid or to inject dye or medication into the amniotic cavity. 
Apgar score: A scoring system to evaluate newborn babies’ condition just after birth. A high 
score indicates newborn well-being (named after Dr Virginia Apgar, an anaesthesiologist). 
Ballottable: The ability, on feeling the abdomen of a pregnant women, to bounce fetal parts 
from one hand to the other. This can be done for the presenting parts above the pelvic brim, 
or for fetal parts higher up (in the fundus) of the uterus.  
Biophysical profile: A scoring system to evaluate fetal condition before birth, based on 
ultrasound criteria. A high score indicates fetal well-being. 
Cardiotocography: Fetal heart rate and uterine contraction recording to assess fetal well-
being. The result is presented as a tracing on a screen or on a paper strip. 
Cephalopelvic disproportion: The disproportion that arises when the fetal head is too large 
to pass easily through the maternal pelvis during birth. 
Fetal distress: Fetal hypoxaemia before birth, usually indicating risk of death.  
Forewaters: Amniotic fluid contained in front of the presenting fetal part at the pelvic inlet. 
Hysterotomy: Incision of the uterus to deliver a fetus or to perform procedures on a fetus. 
Caesarean section is a form of hysterotomy, but implies that the fetus is viable (>28 weeks). 
Intrapartum: Synonym for ‘during labour’. 
Meconium: Sterile fetal intestinal discharge (faeces) passed before, at, or just after birth.   
Nullipara: A woman who has given birth to her first baby. 
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Oligohydramnios: Below-normal total amniotic fluid volume. 
Palpation: Feeling with the hands as part of clinical physical examination of a patient. 
Parity: The number of viable births (>28 weeks) that a woman has had. 
Perinatal: Referring to events that occur at or just after delivery; for example, perinatal death 
refers to death of a baby, either stillborn or within the first seven days after birth. 
Polyhydramnios: Above-normal amniotic fluid volume.  
Pre-eclampsia: Hypertension with protein in the urine, developing after 20 weeks of 
pregnancy.  
Shoulder dystocia. Difficulty or delay with delivery of the shoulders of a baby, after delivery 
of the head, usually associated with above-normal size of the baby. 
Symphysis-fundal height. A measure of the height of the uterus, being the distance in cm on 
the maternal skin, from the symphysis pubis to the highest palpated point of the uterus. 
Term. The traditionally accepted gestational age interval at which normal birth is said to 
occur spontaneously – 37 to 41 weeks. 
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ABSTRACT 
Background and objectives 
In low resource settings, ultrasound scans may not be available for amniotic fluid volume 
(AFV) assessment as part of fetal evaluation for suspected prolonged pregnancies (≥41 
weeks’ gestation). The objectives of this study were: 1) to describe AFV measurements using 
ultrasound in women with suspected prolonged pregnancies, and to relate these 
measurements to maternal and fetal factors; 2) to evaluate different clinical palpation 
methods for estimating AFV; and 3) to determine the ability of clinical palpation to estimate 
AFV and predict oligohydramnios, using ultrasound-based amniotic fluid index (AFI) as a 
gold standard, accounting for the influence of maternal and fetal factors.  
Methods 
The study included women referred to Chris Hani Baragwanath Academic Hospital from 
midwife-run antenatal clinics because of concern about prolonged pregnancy (gestational age 
≥41 weeks). On arrival at hospital, the women had real-time ultrasound assessment of AFI by 
an experienced ultrasonographer. The researcher, blinded to the AFI result, estimated AFV 
by abdominal palpation using ballottability of fetal parts, uterine fluctuance, uterine 
irritability, easily felt fetal parts, and a general impression of AFV. After recording the 
palpation findings, the researcher made a best estimate of gestational age for each woman 
based on the last menstrual period, early pregnancy ultrasound scans if available, or other 
relevant clinical information. Oligohydramnios was defined as an AFI <5 cm. 
Results 
One hundred women participated, of whom 45 had a best estimate gestational age ≥41 weeks. 
The mean AFI was 8.1±4.3 cm; 23 women had an AFI <5 cm. Twenty women were HIV 
12 
 
infected. In univariable and multivariable linear regression analysis, HIV infection and 
gestational age were inversely associated with AFI at a P value <0.05. On abdominal 
palpation, the symphysis-fundal height, uterine fundal fetal parts ballottement, and presenting 
part ballottement were significantly positively associated with AFI on univariable and 
multivariable linear regression analysis. For the binary outcome of oligohydramnios, only 
presenting part ballottement was associated with an AFI <5 cm (negatively), both crudely, 
and adjusted for gestational age and HIV infection using logistic regression analysis. For 
women with a fetal head fully palpable (‘five fifths’) above the pubic symphysis (n=55), an 
inability to ballot the presenting part had a sensitivity of 73%, specificity of 64%, and a 
negative predictive value of 90% for an AFI <5 cm.  
Conclusion 
While fetal part ballottement and symphysis-fundal height measurement showed significant 
associations with AFI, the predictive value of clinical palpation for oligohydramnios was 
poor. However, in settings where real-time ultrasound technology is unavailable, the 
assessment of presenting part ballottement may be of value in women with suspected 
prolonged pregnancy. In clinical settings similar to those in this study, a ballottable fetal head 
gives 90% assurance of normal AFV.       
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1. INTRODUCTION 
The risk of poor pregnancy outcome increases significantly after 40 weeks of gestation, the 
so-called expected date of delivery. Current management of prolonged pregnancy 
(gestation≥41 weeks) is induction of labour or close fetal surveillance, based on reliable 
gestational age assessment usually obtained from early pregnancy ultrasound.
1  
In the absence 
of reliable information on pregnancy dating, it may be difficult to decide on a correct 
management plan. Such a dilemma can be resolved by assessing markers of fetal condition, 
including amniotic fluid volume (AFV).  Reduced AFV (oligohydramnios) will sound a 
warning to possible adverse outcome for the baby. The acceptable response to such a finding 
is admission for delivery, usually by inducing labour. Conversely, a normal AFV, usually 
with good fetal movements perceived by the pregnant woman and a normal fetal heart rate 
(fetal cardiotocographic non-stress test), should allow ongoing close surveillance of the 
pregnancy.  
Ultrasound imaging is the standard method for assessing AFV, by measuring the depth of 
amniotic fluid (AF) pools. There is still debate about the best method of measurement, the 
two alternatives being the deepest or maximum vertical pool (MVP) found in the whole 
uterus, or a sum of the deepest pools in each quadrant of the uterus, termed the amniotic fluid 
index (AFI).
2
  
1.1. Statement of problem 
What about low resource settings where ultrasound equipment and skills are in short supply? 
In such settings, many pregnancies are wrongly classified as prolonged, as they may be 
unreliably dated using only the last menstrual period. This may result in unnecessary 
inductions of labour. Also, AFV assessment using ultrasound may not be available to provide 
reassurance about fetal condition. This dilemma confronts many clinicians who care for 
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pregnant women with suspected prolonged pregnancy in low resource settings. Given the 
risks and expense of induction of labour, it would be understandable to ignore prolonged 
pregnancy and allow nature to take its course and hope for the best in each case. This might 
seem untenable to modern clinicians.  
To provide the reassurance that clinicians and pregnant women need, the seemingly obvious 
alternative to AFV assessment using ultrasound is clinical examination of the pregnant 
woman’s abdomen. Clinical teachers and obstetric textbooks continue to describe findings 
associated with increased, normal and reduced AFV. On clinical examination, fluid can be 
distinguished from solid, and in the obstetric patient a fetus in the uterus can be made to 
bounce (ballot) from side to side if there is sufficient AF.
3,4
 Reduced AFV may give the 
impression of a fetus cramped for movement,
3,5
 or make it easy to feel separate fetal parts.
3,6
  
1.2. Justification for this research 
While modern clinicians may dismiss clinical palpation for assessing AFV, there is little data 
to support such a dismissal. The researcher found only two studies, from 1972 and 1984, that 
evaluated clinical examination for AFV assessment.
7,8
  Both reported that clinical assessment 
was unreliable and of no value. Since the two studies had significant limitations, there is a 
need for further research on clinical methods in AFV assessment, especially in the context of 
prolonged pregnancy where AFV assessment is frequently called for. Of course, this does not 
apply in high-income settings, where shortage of ultrasound equipment is not an issue. The 
potential importance of clinical assessment of AFV in low resource settings remains, and 
needs to be evaluated. 
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2. LITERATURE REVIEW 
2.1. Amniotic fluid volume 
Amniotic fluid and its functions 
Amniotic fluid (AF) is the fluid contained by the amniochorionic membranes in the uterus. It 
provides the watery environment in which the fetus develops. The fluid allows musculo-
skeletal, gastrointestinal and respiratory system development, and also protects the fetus from 
traumatic injury.
9
 AF also has antibacterial properties, and may provide short-term fluid and 
nutrient supplementation to the fetus.
9,10
  
Physiology of amniotic fluid volume 
During the embryonic phase of development (<8 weeks of gestation), AF is no more than an 
ultrafiltrate of maternal plasma. In later weeks the fluid reflects the composition of fetal 
extracellular fluid, with free diffusion of water and solutes though the fetal skin and other 
epithelial surfaces into the amniotic cavity.
11
 Then, in the second half of pregnancy, the fetal 
skin becomes cornified and no longer allows diffusion of fluid. Brace, in an excellent review, 
described the mechanisms of AFV regulation as they are understood in the second half of 
pregnancy.
12   
Briefly, there are four main routes of AF movement at advanced gestation, two 
that produce AF and two that remove AF. The following are daily volumes for a term fetus: 
 AF production: the fetus passes about 800-1200 mL of urine. This is greater than the 
average total AFV (about 800 mL), suggesting a high and rapid turnover of AF. 
 AF production: the fetal lungs secrete about 340 mL of fluid of which about half is 
swallowed and half is delivered to the AF through breathing movements.  
 AF removal: the fetus swallows 500-1000 mL of AF, and this is absorbed in the 
gastrointestinal system.   
16 
 
 AF removal: 200-500 mL of AF is absorbed from the fetal surface of the placenta into 
the placental circulation each day, through the intermembranous pathway. This 
movement is favoured by AF having a relatively low osmolality (about 10 
mOsmol/mL less than fetal plasma)
10
  
Additional but insignificant exchanges occur from the fetal nose and throat into the AF (about 
25 mL), and through the fetal membranes into the maternal circulation, by the trans-
membranous pathway (about 10 mL). 
While some of these exchanges are regulated by fluid and solute status for intermembranous 
transfer, and by fetal kidney perfusion and related mechanisms, it is unlikely that AFV per se 
is regulated. AFV in the second half of pregnancy is highly variable, and in view of the 
turnover of fluid volumes as noted above, can change rapidly.  
2.2. Gestational age and amniotic fluid volume 
It makes intuitive sense that as the uterus enlarges with ongoing pregnancy, AFV will 
increase; the larger the baby, the greater the amount of water in the bag. However, traditional 
obstetric teaching holds that AFV increases to a maximum at about 36 weeks’ gestation, and 
declines thereafter. This is based on a frequently quoted review by Brace and Wolf, published 
in 1989.
13
 The authors combined results from 12 studies in which AFV was measured, either 
directly at hysterotomy or caesarean section, or by dye-dilution techniques. The studies were 
done between 1961 and 1978, on a total of 705 pregnancies. However, in 1997, Magann et al. 
found that AFV increases consistently up to 40 weeks’ gestation, after performing an 
aminohippurate sodium dye-dilution technique on 144 pregnancies from 15-40 weeks of 
gestation.
14
 Their technique involved injection of dye at the time of amniocentesis in ‘normal’ 
pregnancies that had a clinical indication for amniocentesis. After injecting dye and waiting 
for the AF to mix with the dye, they withdrew a specimen which reflected the volume of AF 
17 
 
by the dilution of dye obtained. The aminohippurate sodium dye dilution technique was later 
validated by the same team.
15
 The authors of the 1997 study criticized the Brace and Wolf 
combined analysis, based on small numbers in individual studies, heterogeneity of methods 
used, and inherent inaccuracies with some of the dye-dilution and AF collection methods. 
Their own study had limitations too:  the difficulty in being able to sample entirely normal 
pregnancies, the cross-sectional study design, and the absence of pregnancies of more than 40 
weeks’ gestation. However, it now seems reasonable to believe that AF increases with 
gestation, at least up to 40 weeks, as suggested by Magann et al.
14
  
2.3. Determinants of amniotic fluid volume 
The physiological increase in AFV with advancing gestation has already been discussed. 
Deviations from the norm will result from changes in any of the four main routes of AF 
movement mentioned earlier. Changes in urine output and the fetus’s ability to swallow have 
the greatest effect. A clinically significant increase in amniotic fluid volume is termed 
polyhydramnios, and a decrease oligohydramnios. There are no useful upper and lower limits 
of AFV respectively to define these entities, although gestational age-specific readings can be 
derived from the graphics in published articles.
13,14
 For example, about 95% of measurements 
of AFV at 30 weeks of gestation will be between 100 mL (upper limit for oligohydramnios) 
and 2750 mL (lower limit for polyhydramnios).
14
 Measurement of AFV, including direct 
measurement, dye-dilution methods, noninvasive semiquantitative measurements and 
qualitative estimates, will be discussed later.  
Increase in amniotic fluid volume 
Polyhydramnios is most often associated with fetal abnormalities, related to inability to 
swallow or absorb AF. Examples are gastrointestinal atresias (blockages), mass effects of 
organ enlargements in the neck and chest, and brain defects affecting swallowing reflexes. 
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Other causes include maternal gestational diabetes mellitus, multiple pregnancy, and hydrops 
fetalis.
16
 Increased AFV will not be discussed further in this research report. 
Decrease in amniotic fluid volume 
Oligohydramnios most frequently results from rupture of the membranes during or before 
labour. Oligohydramnios or anhydramnios (no discernible AF) without membrane rupture 
may occur in association with fetal kidney and urine outflow tract abnormalities. Certain 
medications, especially non-steroidal anti-inflammatory drugs, may cause reduced fetal urine 
output resulting in oligohydramnios.
17
 Of most concern to clinicians is oligohydramnios 
caused by reduced uteroplacental perfusion with fetal hypoxaemia. This may result from pre-
eclampsia, fetal infections, chronic placental insufficiency, nicotine use, prolonged 
pregnancy, and maternal dehydration or hypoxaemia.
16,18
 It has been shown that reduced fetal 
oxygenation causes redistribution of oxygenated blood to vital organs, away from the kidneys 
and thus reducing urine output, as evidenced by the demonstration of reduced renal artery 
blood flow on Doppler investigation.
19
 In addition, increased fetal plasma osmolality related 
to reduced uterine perfusion causes a rise in antidiuretic hormone levels and reduced urine 
output, further reducing urine volume and therefore AFV.
9
 The decrease in AFV after 40 
weeks’ gestation is thought to be related, at least in part, to placental insufficiency and fetal 
hypoxaemia. Evidence for this has been provided by the finding of increased erythropoietin 
levels in fetuses at more than 41 weeks’ gestation.20 Concern about failing placental function 
has made AFV measurement an essential component of fetal monitoring in the management 
of pregnancies beyond 41 weeks of gestation. 
The clinical significance of oligohydramnios is not only related to it being a marker of fetal 
hypoxaemia. Oligohydramnios can itself have consequences for the fetus. Early in gestation 
(before 22 weeks), reduced AFV may result in lung hypoplasia and defects in intestinal tract 
19 
 
development.
9,16
 Closer to delivery, oligohydramnios may allow umbilical cord compression 
resulting in fetal hypoxaemia, and also contribute to meconium aspiration syndrome (MAS) 
where the fetus aspirates undiluted irritant meconium into the lungs.
19
  
2.4. Measurement of amniotic fluid volume  
Precise measurement of AFV is only possible by direct or dye-dilution methods, used in 
research settings. In practice, clinicians use ultrasonographic vertical depth measurements of 
AF pools to provide indirect non-invasive semiquantitative measures of AFV. Less 
frequently, qualitative estimates of AFV may also be done using a variety of methods, 
including clinical palpation.  
Invasive ‘gold standard’ measurement 
Direct measurement of AFV can only be achieved at hysterotomy or caesarean section, where 
all AF is collected and measured. Intrauterine fluid is sucked out at the time of incision of the 
uterus, and all remaining fluid is collected in custom-made drapes with pockets. This method 
is well described by Magann et al.
14
 Where there is no clinical indication for hysterotomy or 
caesarean section, the best gold standard measurement of AFV is dye-dilution. At amnio-
centesis (needling of the uterus to remove AF), dye is injected into the amniotic cavity and 
allowed to mix with the AF by external agitation of the uterus or repeatedly withdrawing and 
injecting fluid with the needle still in the uterus. After a certain time, AF is withdrawn and 
AFV is calculated based on the dilution of the dye and the assumption of even mixing of dye 
in the AF. Indigocarmine, aminohippurate and radioactive technetium have all been used as 
dyes,
13
 but aminohippurate is currently the most favoured.
14
 Dye-dilution techniques give 
measurements of reasonable precision for only a short time. Using direct collection at 
caesarean section as a gold standard, Magann et al. showed that dye-dilutions gave erroneous 
20 
 
measurements of AF if the dye-dilution amniocentesis preceded the caesarean section by 
more than four hours.
15
 
Non-invasive qualitative and semiquantitative measurements using ultrasound 
The sonolucent ‘waters’ in the uterus can be easily identified on ultrasound imaging, and it is 
possible to express estimates of AFV from the depth of pools of AF. In 1980, Manning et al. 
described the biophysical profile (BPP) for evaluating fetal health.
21
 The authors had 
recognised that AFV (among other criteria such as fetal heart rate and fetal activity) was an 
indicator of fetal health, and described qualitative measurement of the vertical depth of AF 
pools as a component of the BPP. Normal AFV was assumed if the ultrasound scan showed 
‘fluid evident throughout the uterine cavity. Largest pocket of fluid greater than 1 cm in 
vertical diameter’. Decreased AFV was assumed if ‘fluid absent in most areas of uterine 
cavity. Largest pocket of fluid measures 1 cm or less in vertical axis. Crowding of fetal small 
parts’. These rather arbitrary definitions were backed up by the authors in their series of 216 
high-risk pregnancies, as part of the composite BPP, which was correlated with neonatal 
outcome. The BPP remains to this day an accepted method of fetal evaluation. In 1984, an 
observational study by Chamberlain et al., in which Manning was a co-investigator, showed a 
significant inverse relationship between ultrasonographic AFV estimation and perinatal 
outcome in a sample of 7583 high-risk pregnancies. The increased perinatal mortality rate 
associated with oligohydramnios was related to fetal deaths from intrauterine growth 
restriction and major congenital anomalies.
22
 The authors provided a semi-quantitative 
(admittedly arbitrary) method of expressing AFV: ‘The depth of a pocket (i.e., <1.0 cm, 1.0 
to 2.0 cm, >2.0 to <8.0 cm) was used for classification of cases into decreased, marginal, or 
normal groups, respectively.’ These measurements referred, as in the case of Manning et al.,21 
to the maximum vertical pool (MVP) of AF found in each pregnancy ultrasound scan.  
21 
 
In 1987, to improve on the qualitative and crude semiquantitative measurements of MVP as 
described in the previous paragraph, Phelan et al. introduced the amniotic fluid index (AFI).
23
 
Referring to the MVP measurements, they wrote that ‘these techniques do not permit the 
clinician to follow the progressive changes in the AFV during the course of pregnancy, nor 
do they facilitate total evaluation of the fluid within the intra-uterine cavity’. The AFI relied 
(and still relies) on measuring the vertical diameter of the MVP in each of four quadrants of 
the uterus, as follows:
23
 
‘The approach... begins by first dividing the maternal abdomen into four quadrants. Using the umbilicus as the 
reference point, the uterus is divided into upper and lower halves. The linea nigra is then used as the midline, 
with the uterus divided into right and left halves. The (ultrasound) transducer head is then placed on the 
maternal abdomen along the longitudinal axis. With the transducer head perpendicular to the floor, the largest 
amniotic fluid pocket in each quadrant is identified. Then the vertical diameter of the largest pocket in each 
quadrant is measured. The numbers obtained from each quadrant are summed. This sum is the amniotic fluid 
index, in centimetres, for each patient.’ 
The authors found that AFI declined significantly after 40 weeks. Using an arbitrary lower 
cut-off of 5 cm for oligohydramnios, they found that 2.4% of women of 36-40 weeks’ 
gestation had an AFI  ≤5 cm, while 24% of women at 41-42 weeks had an AFI ≤5 cm. 
Current definitions of oligohydramnios as an AFI <5 cm are derived from this study.  In a 
subsequent study, the same group of authors showed, from data in 197 pregnant women, that 
the AFI increased up to 26 weeks (mean AFI = 19.7 cm) and stabilized, then showed a 
gradual decline from 38 weeks (mean AFI = 16.1 cm) to 42 weeks (mean AFI = 14.1 cm).
24
 It 
is notable that the findings of these studies were not compared to a gold standard AFV, yet 
the AFI was accepted by the authors as creating ‘an adequate impression of the AFV and 
(correlating) well with the changes in AFV during pregnancy’. It seemed to make sense that 
four MVPs from different parts of the uterus should be more helpful than just one. With two 
more articles from the same group correlating the AFI with perinatal outcome, and showing 
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good inter- and intra-observer variability for AFI,
25,26
 the obstetric community was more than 
happy to accept these results. The AFI rapidly came into widespread use around the world as 
a tool for measuring AFV and pregnancy risk. The intuitive appeal and widespread adoption 
of the AFI spawned numerous studies to better define AFI normal limits and the relationship 
of the AFI with AFV. Strong et al. in 1990 showed how AFI increased quite predictably after 
infusion of measured volumes of saline into the amniotic cavity.
27
 Moore and Cayle provided 
one of the first nomograms for AFI in 1990, finding mean AFI measurements of 11.5 cm at 
term (37-41 weeks), and 10.8 cm at 41.1-42 weeks.
28
 They found that an AFI of 5 cm 
corresponded to less than the first centile value at term. Studies of AFI normal ranges 
according to gestation are summarised in Table 1.  
Table 1. Studies of normal values and percentiles of amniotic fluid index (AFI). 
Author Country Number 
of women 
 
Gestational 
ages  
Findings and remarks 
Moore and Cayle 
(1990)
28
 
USA 791 16-44 5
th
 centile at term = 68 mm. AFI <5 cm in 
<1% of scans at term 
 
Marks and Divon 
(1992)
29
 
USA 511 ≥41 weeks AFI ≤5 cm  in 11.5% of scans, 25% 
reduction in AFI for each week beyond 41 
weeks 
 
Alley et al. 
(1998)
30
 
Bulgaria 750 ≥24 weeks Maximal AFI at 28-32 weeks. 5th centile at 
37-41 weeks = 5.4 cm, at >41 weeks = 4.2 
cm  
 
Chauhan et al. 
(1999)
31
 
USA 56 ≥24 weeks No significant differences in AFI from 24-
40 weeks. Significant decrease in AFI from 
40 weeks 
Locatelli et al. 
(2004)
32
 
Italy 3049 ≥40 weeks 
 
AFI ≤5 cm found in 11.5% of scans 
Hinh and 
Ladinsky (2005)
33
 
Vietnam 117 ≥28 weeks Longitudinal study, but no statistical 
techniques used to handle repeated 
measures. Mean AFI at 29 weeks 
(maximum) = 15.1 cm. Mean AFI at 41 and 
42 weeks = 10.3 and 9.3 cm respectively 
 
Machado et al. 
(2007)
34
 
Brazil 2868 ≥20 weeks 50th centile AFI the same from 20 to 33 
weeks. 10
th
 centile at 40, 41 and 42 weeks = 
6.2, 5.3 and 4.4 respectively. 
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While the nomograms from different studies give different ranges, consistent findings are a 
peak in AFI at around 26 to 30 weeks and a sharp decline in AFI after 40 weeks of gestation. 
It has been pointed out that the range of normal values for AFI is very wide, although less so 
for below-normal AFVs. Recently, Machado et al. from Brazil used rigorous methodology to 
measure AFI in 2868 low-risk pregnant women with reliable last menstrual periods 
confirmed by first-trimester ultrasound dating.
34
 Only one AFI was reported per woman, thus 
avoiding any clustering effect of repeated measures. The 10
th
 centile AFIs for women at 40, 
41 and 42 weeks were 6.2, 5.3 and 4.4 cm respectively, providing support for the arbitrary 5 
cm cut-off for oligohydramnios assigned by Phelan et al. in 1987.
23
   
Reproducibility in measurement of AFI has been reported from several studies. In 1990, 
Moore and Cayle showed that measurements were repeatable within 3-7% of an AFI 
measurement, but with higher errors in the oligohydramnios range.
28
 Williams et al. showed 
better intra-observer repeatability with AFI for oligohydramnios at 5
th
 centile cut-offs for 
gestational age (kappa = 0.60) than with one MVP alone at a 2 cm cut-off (kappa = 0.33).
35
 
Alley et al. found mean percentage errors of 2.4% for intra-observer and 3.4% for inter-
observer comparisons,
30
 and Hinh and Ladinsky reported mean percentage errors of 4.8% for 
intra-observer and 12.3% for inter-observer comparisons.
33
 There is general consensus in the 
literature that the AFI is a reproducible measurement, although less so in the setting of 
oligohydramnios. It has justifiably been suggested that measurements in the low range of 
AFV should be repeated to improve precision and reproducibility.
10
    
Amniotic fluid index versus single maximum vertical pool 
With AFI measurement becoming part of routine care of high-risk pregnancies, a number of 
studies, including a meta-analyses, were done to correlate AFI with perinatal outcome.
36,37
 
The overwhelming finding was that AFI was a poor predictor for poor perinatal outcome, 
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leading to re-evaluation of the method and its utility. A large number of studies compared 
MVP (one pool for the whole uterus) with the AFI (MVP in each of the four uterine 
quadrants, added together) for both prediction of AFV and for clinical endpoints. Most 
studies settled on AFI <5 cm or ≤5 cm and MVP <2 cm or ≤2 cm as their definitions of 
oligohydramnios (Table 2). AFI performs marginally better than MVP, which is expected 
since the AFI samples more AF pockets. However, Dildy et al. made the important point that 
both tests gave good correlations with gold standard AFV in the normal range of AFV, but 
with overestimation of AFV in oligohydramnios, and underestimation of AFV in 
polyhydramnios.
38
 Therefore, predetermined cut-offs at low levels may prove more useful for 
assessment of oligohydramnios, rather than assuming correlation based on a full range of 
values.
39
 
Table 2. Studies that compared correlation of maximum vertical pocket (MVP) and amniotic 
fluid index (AFI) with gold standard AF volume.  
Author Country Number of 
women 
 
Gold standard Pearson’s correlation  
coefficient (r) 
Croom et al. 
(1992)
40
 
USA 50 Dye dilution MVP: 0.60 
AFI: 0.75  
 
Dildy et al.  
(1992)
38
 
USA 
 
50 Dye dilution MVP: R
2
=0.74* 
AFI: R
2
=0.71 
 
Horsager et al 
(1994)
41
 
USA 40 Fluid collection at 
caesarean section 
MVP: 0.76 
AFI: 0.74 
 
Magann et al. 
(2000)
39
 
USA 197 Dye dilution PLR for MVP = 2.5† 
PLR for AFI = 2.4 
 
Zaretsky et al. 
(2004)
42
 
USA 80 Fluid collection at 
caesarean section 
MVP: 0.71 
AFI: 0.77 
 
*Coefficient of determination R
2
 from a scale of log-transformed AFI and MVP against log-
transformed AFI 
†PLR = positive likelihood ratio, for oligohydramnios at MVP<2 cm and AFI <5 cm. 
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When AFI was compared with MVP for prediction of poor perinatal outcome, most studies 
found an MVP cut-off of 2 cm as having less false positive results than an AFI cut-off of 5 
cm.
2,43,44
 While AFI may correlate better with AFV as noted above, MVP is currently 
favoured as the standard screening method for fetuses at risk, because of its superior 
predictive value for poor perinatal outcome.
2, 43-47
  
Other imaging methods for AFV assessment 
In 1998, Sherer et al. from the USA considered that the amniotic forewaters might provide a 
significant reservoir of AF, not detectable by measuring vertical pockets on transabdominal 
scans.
48
 Using transvaginal ultrasound, the investigators measured the maximum longitudinal 
distance between the internal cervical os and the presenting fetal scalp. AFI was used as the 
gold standard. Thirty women with normal AFI (>5 cm) and 30 women with reduced AFI (≤5 
cm) participated. The mean depth of forewaters was 0.2 cm in the women with reduced AFI, 
and 0.4 cm in those with normal AFI, a difference that was not statistically significant. Also, 
if the forewaters depth was added to the AFI as a fifth measurement, there was no difference 
in the recalculated AFI. It is possible that the study was underpowered and may have 
delivered a type II statistical error.  
In 2004, Zaretsky et al., from the USA, performed magnetic resonance imaging (MRI) scans 
for AFV in 80 women and compared the results with AFI and MVP by ultrasound scanning, 
against a gold standard of directly collected AFV at caesarean section immediately after the 
scans.
42
 The MRI scans were done before the ultrasound scans, favouring the ultrasound 
scans in terms of time interval to direct collection of AFV. Nevertheless, the MRI 
measurements performed best (r = 0.84), better than AFI (r = 0.77) and significantly better 
than MVP (r = 0.71; p = 0.046). All three methods however had poor accuracy in detecting 
oligohydramnios (defined as AFV <200 mL on direct collection). In view of cost, 
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inconvenience and only marginal improvement over AFI and MVP, MRI scanning is not 
currently favoured for AFV assessment.  
2.5. Clinical assessment of AFV by abdominal palpation 
Obstetric teachers and textbooks frequently describe methods of assessing AFV on clinical 
abdominal palpation. This implies a belief that such assessment will lead to decisions to 
improve pregnancy outcome. Presumably, palpation can detect, or at least suspect, oligo-
hydramnios or polyhydramnios. In its latest edition, the Myles Text Book for Midwives 
describes the clinical signs of increased AFV as ballottable fetal parts (examiner able to 
bounce the parts in the AF from one hand to the other, or between fingers and thumb) and a 
fluid thrill. It describes signs of decreased AFV as being easily felt fetal parts, a small-for-
dates uterus, and a compact feel about the baby.
3
 In his classic text Practical Obstetric 
Problems, Donald wrote that, in examining the abdomen in prolonged pregnancy, oligo-
hydramnios could be appreciated by an impression of ‘ramrod rigidity’ in the fetus.5 A recent 
textbook on clinical signs suggests that clinicians ‘assess liquor volume: is it normal, reduced 
(fetal parts abnormally easy to palpate) or increased (tense with difficulty in distinguishing 
fetal parts)?
’6
 In South Africa, the popular Perinatal Education Programme Maternal Care 
Manual cautions that AF volume is ‘not always easy to feel’ but  that ‘the amount of liquor is 
assessed clinically by feeling the way that the fetus can be moved (ballotted) while being 
palpated’.4 An internet-based clinical teaching guide has a rather sarcastic take on clinical 
AFV estimation and advises students who report on AFV on abdominal palpation that ‘some 
obstetricians may ask about your liquor volume devining (sic) abilities: "Really? The liquor 
volume is normal? Perhaps we should toss out our expensive ultrasound and pay you 
instead”.49    
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Evidence from research 
Despite these appeals to our clinical skill, there is almost no scientific work to validate 
clinical impressions of AFV. Only two studies were found that evaluated clinical palpation 
for assessing AFI, both done in the UK. The first, by Barnes et al., was published in 1972 in 
the pre-ultrasound era.
7
 Ninety-six pregnant women were palpated, and the obstetricians’ 
impression of either ‘reduced’ or ‘normal’ AFV was recorded. The gold standard AFV was 
calculated in each case using a radioactive Technetium dye-dilution technique. Oligo-
hydramnios was defined as AFV <500 mL, a higher cut-off than used in most subsequent 
studies. Dye-dilution results were available for 83 women. The obstetricians’ impressions of 
AFV were found to be unreliable and no better than would be expected by chance. Seventy-
three per cent of pregnancies that turned out to have oligohydramnios were passed off as 
normal on abdominal palpation (Table 3). The problem with this study is that the clinicians 
used only a subjective feel of the abdomen, rather than systematic palpation for ballottability, 
ease of palpation of fetal parts, fetal rigidity, uterine compaction, and uterine fluctuance 
(feeling of fluid in the uterus). Also, the study did not consider factors that could affect 
accurate assessment of AFV, such as maternal body-mass index, level of the fetal head above 
the brim, fetal size and fetal position.  
The second study to evaluate clinical palpation was published by Crowley at al. in 1984.
8 
The 
primary aim was to correlate ultrasound-derived AFV estimates with clinical outcome in 
prolonged pregnancies. The authors briefly mentioned the results for clinical palpation. In 
227 women a ‘senior obstetrician’ was found to have a false positive rate of 25% and a false 
negative rate of 43% for the outcomes of meconium-stained AF and/or absent AF at delivery. 
This corresponds to a sensitivity of 56% and a specificity of 75%, giving an acceptable 
likelihood ratio of 2.2, still less impressive, however, than the likelihood ratio of 7.6 obtained 
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with ultrasound. The authors’ only comment was that clinical examination alone was a ‘poor 
predictor of fetal postmaturity syndrome’.   
Table 3. Results of clinical palpation to assess amniotic fluid volume (AFV), against a gold 
standard Technetium radioactive dye test from which oligohydramnios was defined as AFV 
<500 mL (n=83).
7
 
 Oligohydramnios Normal amniotic 
fluid volume 
 
Totals 
Assessed as reduced 
on palpation 
8 14 22 
Assessed as normal 
on palpation 
22 39 61 
Totals 
 
30 53 83 
Sensitivity = 27%, specificity = 74%, positive likelihood ratio = 1.04. 
The potential value and place of clinical palpation 
There clearly is doubt about clinicians’ ability to detect AFV abnormalities by abdominal 
palpation. However, there is not enough evidence from research to dismiss the clinical 
method, nor is there enough evidence to confirm it as useful. Ultrasound technology, so 
easily available in high-income countries, may not be accessible in low resource regions. 
What of clinical situations where AFV assessment is needed and ultrasound is not available? 
One such situation is prolonged pregnancy, which is associated with increased risks of 
intrapartum asphyxia and stillbirth, meconium aspiration syndrome and postmaturity 
syndrome. Recognition or exclusion of oligohydramnios in prolonged pregnancies facilitates 
decisions on whether to continue with such pregnancies or induce labour, as will be discussed 
later. There is certainly a place for research into the predictive ability of clinical palpation for 
AFV in a low resource setting, with attention to eliminate the methodological deficiencies of 
previous studies.    
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2.6. Prolonged pregnancy 
Definitions 
Current beliefs on the normal duration of pregnancy have not changed since Naegele, a 19
th
 
century German obstetrician, held that a pregnancy should last for 280 days (40 weeks) from 
the first day of the woman’s last menstrual period (LMP).50 The definition of what is 
prolonged has had little refinement over the last 50 years, with most texts still quoting an 
arbitrary 42 weeks or more as being significantly prolonged, or ‘post-term’.50 The American 
College of Obstetrics and Gynaecology, for example, continues to use this definition.
51
 In 
recent decades, concern about increased pregnancy risks at 41 weeks has prompted definition 
of pregnancy ≥41 weeks as ‘prolonged pregnancy’, while keeping a gestation ≥42 weeks as 
‘post-term’.52  In a recent review, Clark and Fleischman suggested that these risks are 
significant enough to assign pregnancies ≥41 weeks as ‘post-term’.50 The terminology is 
further confused by occasional use of the word ‘post-dates’. For this research report, further 
use of the word ‘post-term’ will refer to a gestational age ≥42 weeks. The words ‘prolonged 
pregnancy’ will be used as a deliberately vague hold-all term for pregnancies considered by 
clinicians or researchers to have proceeded significantly beyond their expected duration. 
‘Post-dates’ will not be used except where quoted from the literature.  
Pregnancy dating and diagnosis of prolonged pregnancy 
It is clearly not possible to identify a prolonged pregnancy if there is no certainty about the 
gestational age, just as milk from a dairy cannot be stamped with a ‘use-by’ date if the date of 
milking is not known. Naegele’s rule demands good recall of menstrual dates and relies on 
the assumption that conception takes place 14 days after the first day of the LMP in a regular 
28-day cycle. Use of ultrasound scanning in the first and early second trimester has since 
allowed much better estimation of gestational age.
53,54
  In 2002, regarding dating of 
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pregnancies at term and post-term, Savitz et al. from the USA compared early ultrasound 
scans with LMP information in 5052 women.
53
 The authors found a tendency for pregnancies 
to be reported as longer using the LMP, by an average of 3 days. The proportion of post-term 
pregnancies by LMP was 12.1%, but only 3.4% by early ultrasound scan. There was poor 
agreement (kappa = 0.16) between LMP and ultrasound to agree on term versus post-term 
pregnancy classification. The authors concluded that the LMP is fallible, for three main 
reasons: 1) delayed ovulation, which is more frequent than early ovulation (notably in women 
with oligo-ovulation and women who have recently used hormonal contraception), resulting 
in the expectation of an earlier date of delivery and a higher chance of apparent post-term 
pregnancy; 2) digit preference, with women systematically choosing the 15
th
, followed by the 
1
st
, 5
th
, and 20
th
 day of months; and 3) problems with recall of menstrual dates. Taipale et al. 
reported similar results from Finland in 17721 pregnancies, where the proportion of post-term 
pregnancies was 10.3% by LMP, and 2.7% using ultrasound scanning.
54
 The earlier in the 
pregnancy that scans were done, with fetal crown-rump length used in the first 10 weeks, the 
lower the prediction error rate. In 2005, Van Dyk from Johannesburg reported on 416 women 
who had LMP information and early second-trimester ultrasound scans.
55
 Unpublished data 
from that study showed that the proportion of post-term pregnancies by LMP was 6.5%, and 
by ultrasound scans, 2.6%.
56
 Gardosi et al were likely correct in 1997 when they suggested 
that most post-term pregnancies ascertained by menstrual dates were in fact not post-term and 
were simply cases of wrong dates.
57
 This emphasizes the need, wherever possible, to use 
routine early pregnancy ultrasound scanning if misclassification of term pregnancies as post-
term pregnancies is to be avoided. Indeed, one of the few substantive benefits of routine early 
ultrasound scanning is a decrease in the proportion of inductions of labour for prolonged 
pregnancy, as demonstrated in a Cochrane review by Neilson.
58
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Epidemiology of prolonged pregnancy 
The true frequency of prolonged pregnancy is difficult to determine. Joseph et al. showed that 
differential methods resulted in spurious differences in post-term pregnancy frequencies 
between the USA (6.6%) and Canada (1.0%), because of greater use of early ultrasound 
scanning in Canada.
59
 Therefore, the reported proportions of pregnancies ≥41 weeks (14%) 
and ≥42 weeks (6%) in the USA may be an overestimate.60 In South Africa, Van Dyk found  
that 10.3% of pregnancies reached gestations ≥41 weeks, and 2.6% gestations ≥42 weeks, 
using early second-trimester ultrasound.
56
   
Another artefactual reason for different frequencies of prolonged pregnancies in different 
communities lies in obstetric practices around induction and delivery.
61-63
 For example, 
where it is routine practice to induce labour at 41 weeks, the proportion of pregnancies ≥42 
weeks may be close to zero. Where there are high frequencies of labour induction or primary 
elective caesarean section at term, the proportion of pregnancies ≥41 weeks will be relatively 
low. The frequency of post-term pregnancy may be declining in high-income countries, 
because of these therapeutic practices as well as the almost universal use of early pregnancy 
ultrasound for pregnancy dating.
61
  
A number of maternal, fetal and obstetric conditions predispose to prolonged pregnancy. Rare 
but well-recognised causes include anencephaly and placental sulphatase deficiency, where 
fetal-placental stimuli to the onset of labour are poorly developed.
61
 Large obstetric databases 
from high-income countries have provided opportunities to do retrospective cohort studies to 
determine associations with prolonged pregnancy. In 2009, Caughey et al. reported on a 
cohort of over 110000 pregnancies in the USA, and in a multivariable logistic regression 
model found post-term pregnancy to be significantly associated with obesity, primigravidity 
(first pregnancy), white race, and maternal age >35 years.
64
 In 2010, Roos et al. reported on a 
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Swedish cohort of over one million births and found similar results although the authors did 
not examine the influence of racial group.
65
 Kistka et al., in 2007, added previous postterm 
pregnancy as another predisposing factor.
66
 Two further studies added valuable information 
on the association between obesity and post-term pregnancy.
67,68
 Based on their data and 
good causal evidence, Stotland et al. suggested that for every 14 women brought down one 
body-mass index category, one post-term pregnancy could be prevented.
67
 If this is so, post-
term pregnancy could be prevented by pre-pregnancy weight loss programmes. 
While large databases provide statistical power, and the facility to examine rare outcomes and 
exposures, they are usually derived from routinely collected clinical or registration data. 
There is considerable potential for systematic error in data collection and the retrospective 
cohorts mentioned above are no exception. The most serious potential error is in the detail of 
how the pregnancies were dated. For example, The Swedish post-term frequency was 8.9%, 
much higher than expected in studies where gestational age is measured using early 
pregnancy ultrasound.
65
 
Complications of prolonged pregnancy 
There are undoubted risks related to continuing with prolonged pregnancies. The magnitude 
of these risks was not appreciated until relatively recently. This is because in the pre-
ultrasound era, most ‘prolonged’ pregnancies were simply wrong dates, or normal-length 
pregnancies, as discussed earlier. With more precise dating, much cleaner samples of 
prolonged pregnancies can be analysed. In addition, Hilder et al. pointed out in 1998 that 
analysis of mortality rates per gestational age was inappropriate, and showed that the number 
of ongoing pregnancies should rather be used as a denominator.
69
 The authors, from a 
database of 171527 births, showed that stillbirth rates for London at term (37-41 weeks) were 
2.3 per 1000 term births and at post-term (≥42 weeks) were 1.9 per 1000 post-term births. 
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Yet, when the same data set was used with stillbirth rates per ongoing pregnancies, the 
stillbirth rate was 0.35 per 1000 ongoing pregnancies at 37 weeks, and 1.27, 1.55 and 2.12 
per 1000 ongoing pregnancies at 41, 42 and ≥43 weeks respectively. While these differences 
are small in absolute terms, there is a more than 6-fold increased mortality risk at 43 weeks 
compared to 37 weeks. Similar findings were reported by Smith from Scotland.
70
  
Why the increased risks? Large databases from Scandinavia and the USA have shown post-
term pregnancy to be associated with umbilical cord compression, meconium aspiration 
syndrome, cephalopelvic disproportion, fetal injury, and peripartum asphyxia.
71,72
 
Interestingly, perinatal mortality in post-term babies was highest in those with a birth weight 
<2.5 kg, suggesting that placental insufficiency and growth restriction were likely causal 
factors.  
Part of the explanation for these hazards is found in the extremes of birth weight. The babies 
that grow large because of prolonged pregnancy are more likely to need delivery by 
caesarean section for cephalopelvic disproportion or to be injured at vaginal birth. At the 
lower extreme are infants who are poorly grown and chronically oxygen-deprived. These 
babies are more likely to die in utero, or to suffer asphyxia during labour contractions.  
Oligohydramnios in prolonged pregnancy 
The relative reduction in AFV after 40 weeks of gestation has been discussed earlier. This 
assumes clinical significance, not only as a marker of prolonged pregnancy and diminishing 
placental function, but also as a factor favouring umbilical cord compression and meconium 
aspiration, as mentioned in previous paragraphs. With failing placental function, the fetus 
responds by shunting oxygenated blood away from the kidneys thus reducing urine output 
and therefore AFV. Indeed, low birth weight in prolonged pregnancies has been associated 
with reduced AFI, confirming the mechanisms suggested here.
32
 Crowley et al. in 1984,
8
 and 
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Phelan et al. in 1985,
73
 were among the first to suggest that AFV reduction in prolonged 
pregnancies, as a marker of fetal risk, could be measured by ultrasound, and be used to guide 
clinical management. Prolonged pregnancies with reduced AFV could then be identified as 
being at risk for adverse fetal outcome, and terminated by induction of labour. Crowley et al. 
showed in their small series that prolonged pregnancies with reduced AFV had increased 
frequencies of intrapartum meconium passage, fetal growth restriction, caesarean section for 
fetal distress, and fetal acidemia.
8
 They concluded that assessing AFV was an ‘effective 
discriminatory test in post-term pregnancy’. These early studies set the stage for the current 
management of prolonged pregnancy.      
Management of prolonged pregnancy 
By the late 1980s, easier diagnosis of post-term pregnancy, the emotional impact of 
prolonged pregnancy on women,
61,62
 as well as the clearly defined associated risks, posed a 
management dilemma to obstetricians. Would the risks be avoided completely by inducing 
labour at 41-42 weeks at the cost of the supposed complications of labour induction? Or 
could a middle road be taken by monitoring pregnancies for early signs of trouble using 
discriminatory tests and inducing only where necessary? Randomised controlled trials have 
suggested little difference between the two approaches, although showing a trend to less 
stillbirths and to reduced caesarean section rates with induction of labour.
74
 The results of 
three recent systematic reviews (SRs), with meta-analyses, are summarised in Table 4.
1,75,76
 
The most recent of the SRs suggests that 328 inductions would need to be done to prevent 
one perinatal death, and recommends a policy of induction of labour from 41 weeks.  
Guidelines, most of which pre-dated the two most recent SRs, are available from several 
sources. The UK’s Royal College of Obstetricians and Gynaecologists (RCOG),77 and 
Canadian guidelines, recommend that labour induction be offered between 41 and 42 weeks, 
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with at least twice-weekly antenatal monitoring (AFV and NST) for women declining 
induction.
78
 The World Association of Perinatal Medicine has suggested that ‘both 
management strategies (are) acceptable’ after exclusion of high-risk groups.79 
Table 4. Summary of important findings of three recent systematic reviews and meta-analyses 
of randomized controlled trials comparing management strategies for prolonged pregnancy: 
induction of labour v. expectant care. 
Systematic review Number of trials 
in meta-analysis 
 
Important outcomes reported with relative 
risk (95% confidence interval) 
Cochrane review (2006)
1
 19 MAS: 0.39 (0.09 – 0.99) 
PND: 0.30 (0.09 – 0.99) 
CS (41 weeks): 0.92 (0.76 – 1.12) 
CS (42 weeks): 0.97 (0.72 – 1.31) 
 
Wennerholm et al. (2009)
75
 13 MAS: 0.43 (0.23 – 0.79) 
PND: 0.33 (0.10 – 1.09) 
CS: (41 and 42 weeks): 0.87 (0.80 – 0.96) 
 
Hussain et al. (2011)
76
 15 MAS: 0.43 (0.23 – 0.79) 
PND: 0.31 (0.11 – 0.88) 
CS: (41 and 42 weeks): 0.87 (0.80 – 0.96) 
 
MAS = meconium aspiration syndrome, PND = perinatal death, CS = caesarean section.  
 
The role of amniotic fluid volume estimation in prolonged pregnancy 
It is clear from the above discussion that there is a place for expectant care in prolonged 
pregnancy, with AFV assessment universally recommended along with NST. This is based on 
the expected reduction of AFV after 40 weeks of pregnancy, and also on the reported 
associations between reduced AFV and perinatal complications in prolonged pregnancy, as 
first pointed out by Crowley et al. and Phelan et al.
8,73
 There have been concerns that AFV 
assessment has poor sensitivity and predictive value for poor perinatal outcomes, as discussed 
earlier in this review and acknowledged in the World Association of Perinatal Medicine 
guideline.
79
 Yet, in the absence of a more suitable replacement, the practice of measuring AFI 
or MVP will continue. The RCOG guideline expressed its preference for MVP in line with 
36 
 
published evidence, as discussed earlier.
2
 A Cochrane review on the topic did not find 
‘enough evidence to evaluate tests of fetal well-being’.80 Umbilical and uterine artery 
Doppler studies have proved disappointing for risk assessment in prolonged pregnancies.
81,82
  
Prolonged pregnancy in low resource settings 
Reduction of high perinatal mortality rates has emerged as a priority for low resource settings 
such as in sub-Saharan Africa.
83,84
 Global advocates for improved perinatal care have noted 
that routine induction of labour at ≥41 weeks may be of value, and have incorporated this 
clinical policy into pregnancy care recommendations that include less-developed countries.
85
 
This is inherently problematic because the evidence base for routine induction at ≥41 weeks  
is derived from research done mostly in high-income settings where: 1) early pregnancy 
antenatal care is the norm; 2) ultrasound scanning is easily available; and 3) induction of 
labour is closely monitored and considered safe. It is likely that most maternity services in 
sub-Saharan Africa do not fulfil even one of these three conditions, which are all essential to 
detection of post-term pregnancy and its evidence-based management. 
Post-term pregnancy certainly occurs in low resource settings. Data is scarce for sub-Saharan 
Africa. Geerts et al., in an RCT on early pregnancy ultrasound in Cape Town, found post-
term pregnancy rates of 2.0% and 8.4% in women having and not having early pregnancy 
ultrasound respectively.
86
 In similar work from Johannesburg cited earlier, van Dyk found 
corresponding rates of 2.6% and 6.5%.
56
 A Nigerian study on outcomes in elderly nulliparas 
found a post-term pregnancy rate of 17% in under-35 nulliparas, presumably in the absence 
of early pregnancy ultrasound dating.
87
 It is thus likely that most post-term pregnancies 
detected in the absence of early pregnancy ultrasound are not post-term at all, as observed 
earlier.
57
 Therefore, a policy of induction of labour would, using menstrual dates alone, affect 
6.5 to 17% of pregnancies. The current South African national guideline recommends, 
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without mentioning ultrasound, that after ensuring that the gestational age has been correctly 
calculated, labour should be induced at ≥41 weeks.88 This can only bring additional strain to 
struggling health services and may result in a burden of complications related to unnecessary 
and poorly monitored induction of labour.
89
 A reasonable local response in South Africa has 
been to screen women with AFV measurement if they present with suspected prolonged 
pregnancy,
90
 to replicate expectant management groups in RCTs for post-term induction of 
labour.
1
 While this approach seems a sensible way of reducing the number of inductions, it 
has not been scientifically evaluated. Moreover, it again relies on ultrasound scanning to 
assess AFV, and may not be available in low resource settings. Only clinical palpation, 
currently of no proven value, presents an alternative to ultrasound assessment of AFV.  
A comprehensive search of published scientific literature could find only one article that 
addressed management of post-term pregnancy in sub-Saharan Africa. Otoide and Okonofua 
described their experiences of induction of labour at 41-42 weeks in a Nigerian teaching 
hospital, and found that outcomes were generally good.
91
 Gestational age was determined by 
certain dates or early ultrasound if available. The study’s results reflect practice in a teaching 
centre and do not really address low resource settings in sub-Saharan Africa, from which 
there appears to be no data. An unpublished report by Brand et al. from Cape Town in 1993 
found that women referred for ‘post dates pregnancy’ often had uncertain dates and, in 
general, did not require induction of labour.
92
 Amniotic fluid volume was inversely related to 
need for caesarean section. Perhaps, in Africa, post-term pregnancies are wished away by 
women and their caregivers, in the certain knowledge that all gestations will come to a 
spontaneous end, usually (but not always) with pleasing outcomes. This approach should not 
be surprising, given late initiation of antenatal care, the difficulties with pregnancy dating, 
and the risks of unnecessary inductions. Yet, post-term pregnancy in these settings presents a 
compelling dilemma, worthy of research.      
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3. RESEARCH QUESTION 
There remains a gap in knowledge about the value of clinical palpation in assessing AFV. 
Should clinical palpation be sufficiently predictive of AFV, it could offer a simple, cheap and 
rapid method of assessing whether a suspected prolonged pregnancy should be considered for 
labour induction. This may not have value in high-income settings with easy access to 
ultrasound scanning, but could prove useful in low resource settings.  
3.1. Aim of this study 
This study attempted to find out whether AFV estimation by clinical palpation correlated well 
with AFV estimation by ultrasound in pregnancies suspected to be prolonged. 
3.2. Objectives 
The specific objectives of the study were: 
1. To describe the maternal, fetal and obstetric characteristics, and clinical outcomes, of 
suspected prolonged pregnancies in women presenting at Chris Hani Baragwanath 
Academic Hospital antenatal clinic from July to September 2011. 
2. To describe AFV measurements using ultrasound methods, in women with suspected 
prolonged pregnancies, and to investigate how these measurements are related to 
maternal and fetal factors. 
3. To describe and evaluate clinical palpation methods for estimating AFV.  
4. To determine the predictive ability of clinical palpation to estimate AFV and predict 
oligohydramnios, using the ultrasound method as a gold standard, accounting for the 
influence of maternal and fetal factors.  
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4. METHODS 
4.1. Study design 
This was a cross-sectional analytic study. All data, except for the ultrasound scan, was 
collected by one researcher, who is an experienced clinical specialist on the staff of the 
Department of Obstetrics and Gynaecology at Chris Hani Baragwanath Academic Hospital. 
4.2. Setting 
Chris Hani Baragwanath Academic Hospital (CHBAH) is a referral centre for midwife-run 
antenatal services in the surrounding areas of Soweto, Orange Farm and Lenasia. Routine 
antenatal care is conducted at these services, and problem cases are referred to the unit at 
CHBAH. All pregnancies suspected to have reached 41 completed weeks of gestation are 
referred. From experience of working in the antenatal clinic, the suspicion of prolonged 
pregnancy is most frequently based on a menstrual history, or an estimate based on fetal size 
at an earlier gestation. The gestational age is therefore frequently in doubt. Hospital clinicians 
may request an ultrasound scan in such cases to look for oligohydramnios (AFI <5 cm), and 
such a finding will likely result in a decision to induce labour. Where the gestational age is 
≥41 weeks based on good evidence such as early pregnancy ultrasound or reliable dates based 
on certain LMP, induction is offered irrespective of AFI findings, in line with evidence from 
randomized trials and South African guidelines.
1,88
 Close surveillance with twice-weekly 
antenatal monitoring (AFV and non-stress testing) is rarely done.   
4.3. Study population 
The study population was all women referred to CHBAH from midwife-run clinics with a 
suspicion of prolonged pregnancy (≥41 weeks’ gestation), irrespective of age or parity. If 
women were found on assessment at CHBAH to be <41 weeks pregnant, they were still 
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included because they represented the clinical problem of suspected prolonged pregnancy. 
Only singleton pregnancies with live babies were included in this study. Women under the 
age of 18 years, as well as those referred for hypertension in pregnancy, breech presentation, 
diabetes mellitus and prelabour rupture of the membranes, and those with previous caesarean 
section, were excluded. Those found incidentally to be hypertensive (two readings of systolic 
blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg), or with breech 
presentation, were included as they had been referred only for prolonged pregnancy. 
4.4. Sampling  
A sample of eligible women was drawn on days that the researcher was able to be at the 
antenatal clinic at CHBAH. Depending on the time available, up to four women were 
recruited on a morning, almost always the first four that presented themselves. This was done 
so that the women could have ultrasound scans early before long queues developed.   
No data from research was available to inform a sample size calculation. The researcher 
estimated, from experience of working at CHBAH, that the frequency of oligohydramnios 
determined by AFI in suspected prolonged pregnancies would be about 10%. In such a 
population, to show statistical significance for clinical palpation to detect oligohydramnios 
with a sensitivity of 75% and a specificity of 75%, with 80% power (1-β) and at a 
significance level (α) of p=0.05, a sample of 101 women was required.   
4.5. Data collection 
The researcher asked the attending nurses in the antenatal clinic to point out which women 
had been referred for suspected prolonged pregnancy. After confirming the reason for referral 
by reading the referral note in the appropriate block on the antenatal card, the researcher 
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informed the woman of the reason for the study, and directed her to the ultrasound scanning 
room.  
The ultrasound scan 
All ultrasound scans were performed with a Siemens Sonoline G50 ultrasound scanner using 
a 3.5 MHz curvilinear transducer. The ultrasonographer was an experienced Health 
Professions Council of South Africa-certified professional with a bachelor’s degree in 
ultrasound scanning. She was aware of the research, and in each case completed a custom-
made ultrasound report (Appendix A). This included estimated fetal weight using the 
Hadlock formula based on biparietal diameter, abdominal circumference and femur length,
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and deepest AF pool depth in each of the four uterine quadrants, summed to an AFI, 
according to the method of Phelan et al.
23
  The deepest pool found was noted as the MVP. If 
the AFI was less than 10 cm, the ultrasonographer repeated the measurements immediately, 
and the mean of the two AFI measurements was then used. If there was a multiple pregnancy 
or any major fetal abnormality, the woman was excluded from the study at that stage. The 
ultrasonographer did not discuss the AFI findings with the woman, and folded up the report 
and inserted it into the woman’s file. The woman was then sent back to the researcher for 
clinical assessment. 
Explanatory variables 
Within one hour after the ultrasound scan, a full clinical assessment, blinded to the ultrasound 
report, was made by the researcher. The only difference from the normal routine was that the 
physical examination was done first and data entered, followed by the history and reading of 
the antenatal card. This reversal of the usual order was done to prevent biased clinical 
palpation assessments related to the history, especially the gestational age. The woman’s 
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height was measured using a calibrated tape-measure attached to the wall. This was followed 
by a general physical and obstetric examination.  
The primary explanatory variables were various clinical methods of assessing AFV. These 
included eliciting ballottement (present or absent) of the fetus or fetal parts inside the uterus 
in: 1) the uterine fundus, and 2) the lower pole of the uterus, where the presenting part is 
situated. In addition, 3) presence or absence of fetal compaction or rigidity was determined, 
as well as 4) ease of palpating fetal parts (yes or no), and 5) presence or absence of fluctuance 
(impression of fluid content) of the uterus including a fluid thrill.  
Further clinical observations on abdominal examination included symphysis-fundal height 
(SFH) measurement, from the upper edge of the pubic symphysis in the midline to the highest 
palpated point on the uterus, not necessarily in the midline, according to the method 
described in the Perinatal Education Programme.
4
 This was measured twice with a soft tape-
measure and averaged. Also assessed were abdominal circumference (measured once from 
the small of the back to include the widest part of the abdomen), uterine irritability (binary 
variable defined as a contraction developing during the palpation), and level of fetal head felt 
above the pelvic brim in fifths (from five fifths being the highest, to zero fifths being not 
palpable at all and fully descended, using the fingerbreadths method described by 
Notelowitz).
94
 Finally, the researcher noted his general impression of AFV, either normal, or 
reduced (oligohydramnios) based on the whole abdominal examination. 
The researcher then made a cervical assessment (Bishop score, out of possible maximum of 
13) to determine favourability for induction of labour. Whenever the cervix admitted at least 
a finger-tip, irrespective of gestational age assessment, sweeping of the membranes was 
performed to facilitate the onset of labour.
95
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Following his examination, the researcher called a consultant colleague from a neighbouring 
examination room in the antenatal clinic to estimate AFV by abdominal palpation, using 
whatever criteria the colleague might find useful. The colleague was asked to give a general 
impression of AFV, stating if this felt reduced or not. The colleague was aware that the 
woman was referred for prolonged pregnancy, but did not have access to any other 
information on gestational age.    
Other explanatory variables were collected by the researcher, including possible confounders 
or effect modifiers, and included maternal age in completed years on the day of referral, 
parity (number of previous pregnancies carried to 28 weeks or more), HIV status and 
smoking. The maternal weight at first antenatal care visit was recorded, as the closest 
available measure to pre-pregnancy weight. Gestational age was calculated after palpation 
findings were noted, as follows: 1) an early ultrasound scan (≤24 weeks) from private or 
public providers was accepted as the correct gestational age; 2) if no early ultrasound scan 
was available, the first day of the last menstrual period (LMP) was used as the reference point 
of zero weeks; if there was uncertainty about LMP, a late ultrasound scan (>24 weeks) was 
used; in the absence of any of these findings, estimates based on palpation and/or SFH 
measurement at antenatal clinic were used. The study data sheet is attached as Appendix B. 
Outcome variables 
After entering all explanatory variable data, the researcher unfolded the ultrasound report and 
entered the AFI and MVP findings onto the data sheet. The primary outcome measure was 
AFV determined by AFI. Oligohydramnios was defined as an AFI <5 cm. AFI was chosen 
over MVP because intuitively and from evidence AFI shows slightly better correlation with 
AFV,
38,40-42
 and has previously been used as a gold standard measure for AFV.
48 
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The researcher was then able to use the information from the ultrasound report to plan 
management for the woman. While management plans were individualized, they followed the 
clinical protocols in the department. The protocol on prolonged pregnancy recommends 
induction of labour for women considered to be at ≥41 weeks’ gestation, and in cases of 
doubt about gestation, induction if AFV is reduced. The decision to admit for induction, or to 
discharge home, was noted in the data sheet. 
All women were followed up to delivery. Delivery dates and outcomes (induced or 
spontaneous labour, place of delivery, mode of delivery, birth weight, five-minute Apgar 
score, neonatal admission, baby’s sex, neonatal unit admission with reasons, and perinatal 
death) were extracted from the birth registers in Chris Hani Baragwanath labour ward as well 
as MOUs in Soweto, Orange Farm and Lenasia. The MOUs were visited regularly to 
determine final outcomes of all participants. Full in-patient files were not requested from the 
records department unless there was doubt about caesarean section indication or whether 
induction of labour occurred.  
4.6. Data analysis 
Data management and analysis was done using STATA version 11 (STATA Corp, College 
Station, Texas, USA) software. Frequencies and percentages for counts, and means ± 
standard deviations, or medians with interquartile ranges for continuous variables as 
appropriate were used to describe the data. Pearson’s correlation co-efficient was used to 
determine correlations of continuous variables. Inter- or intra-observer variation in clinical 
and ultrasound observations was determined using Cohen’s kappa statistic for categorical 
measures, and intraclass correlation for continuous measures. The McNemar test with exact p 
value calculation was done for paired binary observations. 
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To investigate the association between maternal and fetal factors on continuous levels of AFI 
obtained by ultrasound, univariable linear regression was used. For dichotomized levels of 
ultrasound-obtained AFI (oligohydramnios) as the outcome variable, univariable logistic 
regression was performed for continuous and categorized explanatory variables. 
Multivariable linear and logistic regressions for continuous and categorized AFI respectively 
were used to identify independent maternal and fetal predictors for AFV after adjustment for 
the influence of covariates. Explanatory variables with p-values <0.2 in univariable models 
were included for consideration in the multivariable models.   
The associations between AFI and potentially predictive elements of clinical palpation were 
then investigated using univariable linear regression analysis for the continuous AFI outcome 
variable. For categorized binary levels of AFI (oligohydramnios) as the outcome, univariable 
logistic regression was used. Elements of clinical palpation found to be significantly 
associated with oligohydramnios were then placed alongside statistically significant maternal 
and fetal predictors for AFI, as described in the previous paragraph, in multivariable models 
to determine their predictive value after adjustment for the maternal and fetal predictors.  
Linear regression analysis was done considering all assumptions with appropriate testing, 
such as normally distributed continuous outcome (histograms and tests for normality), 
linearity of association (‘qnorm’ and ‘pnorm’ in STATA), normal distribution of variance 
(histograms), homogeneity of variance (homoskedasticity) and the influence of outliers with 
sensitivity analysis, using dfbeta analysis. Interaction terms were tested and included where 
appropriate. Logistic regression analysis included interaction terms where necessary, and 
nested models were compared with larger models using the likelihood ratio test.   
For clinical observations found to have predictive value for oligohydramnios at a cut-off level 
of AFI, sensitivity, specificity, positive and negative predictive values, and positive and 
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negative likelihood ratios were computed. ROC curves were drawn for predictive 
observations with area under the curve calculated. Unadjusted and adjusted (for maternal and 
fetal factors after logistic regression analysis) curves were drawn.   
Statistical comparisons, when not done using regression analysis, were made using Fisher’s 
exact test for categorical variables, and Wilcoxon’s rank sum test for continuous variables.  
In all statistical comparisons, p-values <0.05 were used to define statistical significance.   
4.7. Ethics  
This was an observational study with the clinical examination for AFV not influencing 
clinical decisions, as all participants underwent ultrasound assessments. No additional 
examinations or ultrasound scans other than those done routinely in the clinical situation of 
suspected prolonged pregnancy were done. Informed consent was obtained from all 
participants who were assured that all data would be anonymized on the data sheets. The 
information and consent form is attached as Appendix C. Approval for conduct of this study 
was obtained from University of the Witwatersrand’s Human Research and Ethics Committee 
(approval number M110111, dated 28 January 2011, attached as Appendix D). 
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5. RESULTS 
5.1. Maternal, fetal and obstetric characteristics and outcomes  
One hundred women participated in the study. Their mean age was 25.7 ± 6.0 years. Forty-
four percent were nulliparous. There were 11 women with incidental hypertension, of whom 
1 had severe pre-eclampsia. Twenty women were HIV infected, with 13 on highly active 
antiretroviral therapy (HAART). The names of the drugs in the HAART regimens were 
recorded. The mean maternal weight (available for 96 women) was 72.3 ± 12.4 kg, and  
height was 160.5 ± 5.1 cm; 24 women (25%) were classified as obese (BMI ≥30 kg/m2).  
Based on LMP, available in 86 women, the mean gestational age was 40.2 ± 2.2 weeks. The 
best estimate of gestational age was based on LMP in 52 women, and on early ultrasound 
(≤24 weeks) in 26 (Table 5). The mean gestational age by best estimate was 39.9 ± 1.5 
weeks; 45 women had a best estimate gestational age  ≥41 weeks, determined by LMP in 20, 
early pregnancy ultrasound in 10, later ultrasound in 4, and other methods in 11 women.  
Table 5. Gestational age estimation in women referred for suspected prolonged 
pregnancy (n=100). 
Gestational age in weeks by best estimate (median with range) 
 
40 (34 – 43)  
Gestational age in weeks by best estimate:           <37 
                                                                               37-38 
                                                                               39-40 
                                                                               41 
                                                                               ≥42 
 
4 
11 
40 
40 
5 
Method of obtaining best estimate:         ultrasound ≤24 weeks 
                                                                 last menstrual period 
                                                                 ultrasound >24 weeks 
                                                                 first clinical palpation  
                                                       
26 
52 
9 
13 
Ultrasound scans during antenatal care:        none 
                                                                       private provider 
                                                                       public provider 
                                                                       both public and private 
                                   
47 
37 
14 
2 
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The researcher admitted 44 of the 100 women for delivery. The most frequent reasons for 
admission were gestation ≥41 weeks (n=25), hypertension (n=6), gestation ≥41 weeks with 
hypertension (n=5), and oligohydramnios (AFI <5 cm) at <41 weeks (n=7). Forty-two of the 
admitted women underwent induction of labour. A further 8 women required induction of 
labour section after further follow-up by other clinicians. Thirty-five women required 
caesarean section, the most frequent indication being fetal distress (n=24; 69%). Fifteen of 
the 56 women not admitted (27%) went on to deliver at MOUs. The mean birth weight was 
3305 ± 414 g. There were 53 male infants (54%; one newborn’s sex was not recorded). There 
were no stillbirths, no neonatal deaths, and no cases of MAS or neonatal encephalopathy.  
5.2. Ultrasound estimation of amniotic fluid volume 
The mean AFI was 8.1 ± 4.4 cm, with a median of 7.9 cm and a range of 0-22.5 cm. Twenty- 
three women had an AFI <5 cm. The ultrasonographer took two measurements of AFI where 
the AFI was <10 cm, and in those instances (n=64) a mean of the two measurements was 
taken. The intraclass correlation between the first and second AFI measurements was 0.96 
(95% CI 0.92; 0.99). The AFI measurements were normally distributed (Figure 1).  
 
Figure 1. Histogram and box-and-whisker plot, showing frequency distribution of 
amniotic fluid indices (n=100)  
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5.3. Clinical examination 
The findings of the researcher’s clinical examination are shown in Table 6. The mean 
symphysis-fundal height (SFH) was 37.9 cm (range 31.5-43.5 cm). The fetal head was felt at 
five fifths above the brim in 55 women (56%). Using Fisher’s exact test, there was no 
statistically significant association between level of the head in fifths and gestational age ≥41 
weeks (p=0.08, data not shown). The presenting part could not be ballotted in the uterus in 66 
women.  
Table 6. Findings on clinical abdominal measurement and palpation. All observations 
were made without knowledge of the ultrasound scan results (n=100). 
Finding 
 
n (%)* 
Symphysis-fundal height in cm (mean ± SD) 
 
37.9 ± 2.6  
Abdominal circumference in cm (mean ± SD) 
 
101.9 ± 6.8 
Level of the fetal head in fifths (n=99):†                  5 
                                                                                   4 
                                                                                   3  
 
55 (56%) 
31 (31%) 
13 (13%) 
Uterine irritability 
 
28 
Fetal parts not ballottable in the uterine fundus 
 
75 
Presenting part not ballottable suprapubically 
 
66 
Impression of fetal compaction 
 
13 
Fetal parts easy to feel 
 
41 
Failure to elicit uterine fluctuance 
 
18 
General impression of oligohydramnios by researcher 
 
28 
General impression of oligohydramnios by colleague 
 
37 
*Percentages not shown if n=100. †There was one breech presentation 
The colleague who was asked to give a general estimate of AFV was a consultant (specialist) 
in 95 cases and a registrar (trainee specialist) in 5 cases when a consultant was not available. 
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The colleagues made up 15 consultants and 3 registrars. The kappa statistic for inter-observer 
agreement between the researcher and the colleagues was 0.03 (standard error=0.10; p=0.38), 
indicating no agreement in assessment of AFV by general impression. The McNemar test for 
paired observations showed no significant trend to over- or under-estimation of AFV by 
researcher or colleagues relative to each other (p=0.22) (Table 7). 
 
Table 7. Inter-observer agreement for general impression of AFV by researcher and by 
consultants (n=100) 
 Reduced AFV  by 
colleague 
 
Normal AFV by colleague 
Reduced AFV by 
researcher 
 
11 17 
Normal AFV by 
researcher 
 
26 46 
 
When the researcher considered the AFV to be reduced (n=28), the mean AFI was 7.0 ± 3.5 
cm, and when he considered the AFV to be normal (n=72), the mean AFI was 8.5 ± 4.5 cm 
(p=0.11). The corresponding values for the colleagues were an AFI of 8.3 ± 4.5 cm for 
reduced AFV (n=37) and 8.0 ± 4.2 cm for normal-feeling AFV (n=63) (p=0.75).  
The researcher correctly predicted reduced AFV in 7 out of 23 women (sensitivity of 30%) 
who were found to have an AFI <5 cm, and the colleagues correctly predicted reduced AFV 
in 8 women (sensitivity 35%) (Table 8). Corresponding specificities were 73% (56/77) for the 
researcher and 62% (48/77) for the colleagues.   
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Table 8. Association between researcher and colleagues’ impression of amniotic fluid 
volume (AFV) and finding of amniotic fluid index (AFI) <5 cm on ultrasound 
(oligohydramnios) (n=100). 
 AFI on ultrasound 
 
 
p value 
<5 cm (n=23) 
 
≥ 5 cm (n=77) 
Researcher impression of reduced 
AFV 
 
7 (30%) 21 (27%) 0.80 
Colleagues’ impression of reduced 
AFV 
 
8 (35%) 29 (38%) 1.00 
 
 5.4. Maternal and fetal characteristics and amniotic fluid index 
Univariable (unadjusted) linear regression for the continuous outcome of AFI showed no 
statistically significant associations with antenatally measured maternal and fetal predictors, 
except for inverse correlations with gestational age (p<0.01) and HIV infection (p=0.01) 
(Table 9). The univariable statistical trend for maternal weight (p=0.18) in the univariate 
model was not confirmed in a multivariable linear regression model. The multivariable model 
for AFI included only gestational age and HIV status as independent predictors of AFI (Table 
10). The result for gestational age suggests that for each increased week of gestation in the 
ranges measured in this study, the AFI reduces by 0.80 cm, with a 95% confidence interval of 
0.27 to 1.33 cm after adjustment for HIV status. The association with HIV status prompted an 
examination of the influence of highly active antiretroviral therapy (HAART). The median 
AFI for women on HAART (n=13) was 4.9 cm and the median AFI for women not on 
HAART (n=7) was 5.8 cm. Using the Wilcoxon ranksum test, this difference was not 
statistically significant (p=0.50). 
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Table 9. Univariable linear regression analysis for amniotic fluid index (AFI) against 
maternal and fetal characteristics (n=100). 
Explanatory 
variable 
Constant Beta-
coefficient 
 
Standard 
error 
 
95% CI  P value 
Maternal age in years 
 
 
9.70 -0.06 0.07 -0.21; 0.08 0.38 
Parity ≥1 (reference 
para 0) 
 
8.61 -0.96 0.87 -2.68; 0.76 0.27 
Gestational age in 
weeks 
 
43.53 -0.89 0.27 -1.43; -0.35 <0.01 
HIV infected (ref-
erence HIV negative) 
 
8.60 -2.64 1.05 -4.72; -0.56 0.01 
Maternal height in cm 
 
 
9.72 -0.01 0.09 -0.18; 0.16  0.91 
Maternal weight in kg  
 
 
11.42 -0.05 0.04 -0.12; 0.02  0.18 
Body-mass index  
 
 
10.88 -0.10 0.09 -0.28; 0.07 0.25 
Estimated fetal weight 
in g 
 
5.75 0.001 0.001 -0.001; 0.002 0.46 
Male fetal sex 
(reference female) 
 
8.72 -1.22 0.87 -2.94; 0.50 0.16 
 
 
 
Table 10. Multivariable linear regression model for amniotic fluid index (AFI) (n=100). 
Explanatory variable Beta-
coefficient 
Standard 
error 
 
95% CI  P value 
Gestational age in weeks 
 
 
-0.80 0.27 -1.33; -0.27 <0.01 
HIV infected (reference HIV 
negative 
 
-2.18 1.02 -4.20; -0.16 0.04 
Equation:  AFI = 40.47 – 0.80(gestation in weeks) – 2.18 (HIV infected); R2 = 0.14. 
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For the measure of oligohydramnios at an AFI cut-off <5 cm, maternal and fetal 
characteristics were compared with respect to oligohydramnios and normal AFV using 
univariable logistic regression (Table 11). Only gestational age (40.7 weeks with 
oligohydramnios v. 39.7 weeks with normal AFV; p=0.01), HIV status (35% positive v. 16% 
positive; p=0.05) and mean maternal weight (75.4 kg v. 71.3 kg; p=0.18) showed trends 
towards an association with reduced AFI.  
Table 11. Comparison of maternal and fetal characteristics in women with oligo-
hydramnios (amniotic fluid index <5 cm) and normal amniotic fluid index, by 
univariable logistic regression (n=100). 
Explanatory variable Oligo-
hydramnios 
(n=23) 
 
Normal 
AFV 
(n=77) 
Odds ratio (95% 
CI)  
P value 
Maternal age in years (mean 
± SD) 
 
26.5 ± 6.3 25.5 ± 5.9 1.03 (0.95; 1.11) 0.47 
Parity ≥1 (reference para 0) 
 
 
14 (61%) 42 (55%) 1.30 (0.50; 1.84) 0.59 
Gestational age in weeks 
(mean ± SD) 
 
40.7 ± 1.0 39.7 ± 1.6 1.84 (1.13; 3.00) 0.01 
HIV infected (reference HIV 
negative) 
 
8 (35%) 12 (16%) 2.89 (1.01; 8.31) 0.05 
Maternal height in cm (mean 
± SD) 
 
161.0 ± 4.4 160.3 ± 5.2 1.03 (0.93; 1.13) 0.59 
Maternal weight in kg (mean 
± SD) 
 
75.4 ± 13.6 71.3 ± 12.0 1.03 (0.99; 1.07) 0.18 
Body-mass index (mean ± 
SD) 
 
29.1 ± 5.0 27.8 ± 4.9 1.05 (0.96; 1.15) 0.30 
Estimated fetal weight in g 
(mean ± SD) 
 
3682 ± 477 3630 ± 520 1.00 (1.00; 1.00) 0.67 
Male fetal sex (reference 
female) 
 
15 (65%) 38 (50%) 1.88 (0.71; 4.94) 0.20 
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In a multivariable logistic regression model for the binary outcome of oligohydramnios, only 
gestational age showed a statistically significant association (adjusted odds ratio 1.90; 95% 
CI 1.09-2.97) (Table 12). Although removal of HIV status from the model with gestational 
age showed no statistically significant difference using the likelihood ratio test, HIV status 
was retained in the model because of its clinical significance given the findings in the linear 
regression analysis for AFV in Tables 9 and 10.   
 
Table 12. Multivariable logistic regression model for oligohydramnios (amniotic fluid 
index < 5 cm) versus normal amniotic fluid index for maternal and fetal characteristics 
(n=100). 
Explanatory variable Adjusted 
odds ratio 
Standard 
error 
 
95% CI  P value 
Gestational age in weeks 
 
1.80 0.46 1.09; 2.97 0.02 
HIV positive status 
 
2.47 1.39 0.82; 7.43 0.11 
 
5.5. Association of clinical assessments with amniotic fluid index 
The association of each of the clinical measurements and assessments with AFI was tested in 
univariable linear regression analysis (Table 13). SFH (p=0.03), fundal ballottability (p<0.01) 
and presenting part ballottability (p<0.01) showed statistically significant negative 
associations with AFI. A trend to significance was shown with level of head five fifths 
(p=0.05). A composite measure of non-ballottability of the fetal parts in the fundus, non-
ballottability of the presenting part, and an SFH <39 cm was tested as a marker of 
oligohydramnios. There were 43 women in whom this combination was found. The 
composite measure was significantly associated with AFI (p<0.01). These four elements of 
physical examination were each placed in separate multivariable linear regression models 
alongside gestational age and HIV, which were the maternal and fetal characteristics found to 
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be significant in regression for AFI. Symphysis-fundal height, fundal ballottability, 
presenting part ballottability and the composite measure all remained statistically 
significantly associated with AFI after adjustment for gestational age and HIV status (Table 
14). A level of head of five fifths or more did not attain statistical significance in a 
multivariable model (p=0.10) (data not shown).  
Table 13. Univariable linear regression analysis for amniotic fluid index, for clinical 
signs on abdominal and vaginal examination (n=100). 
 Constant Beta co-
efficient 
 
Standard 
error 
95% CI P value 
Symphysis-fundal height 
(SFH)  in cm 
 
-5.52 0.36 0.16 0.04; 0.68 0.03 
Abdominal circumference in 
cm 
 
13.08 -0.49 0.06 -0.18; 0.08 0.44 
Head five fifths palpable* 
 
 
7.16 1.67 0.85 -0.03; 3.36 0.05 
Uterine irritability† 
 
 
8.00 0.26 0.96 -1.65; 2.17 0.79 
Fundal parts not ballottable† 
 
 
10.32 -2.99 0.95 -4.88; -1.10 <0.01 
Presenting part (PP) not 
ballottable† 
 
9.75 -2.54 0.88 -4.28; -0.80 <0.01 
Fetal compaction† 
 
 
8.24 -1.29 1.28 -3.83; 1.24 0.31 
Fetal parts easy to feel† 
 
 
7.32 1.28 0.87 -0.45; 3.00 0.14 
Failure to elicit uterine 
fluctuance† 
 
8.29 -1.21 1.12 -3.43; 1.01 0.28 
Composite measure:   
PP and fundal parts not 
ballottable, SFH <39 cm† 
 
9.28 -2.81 0.83 -4.45; -1.17 <0.01 
Binary explanatory variables: *reference is head 4 fifths or less; †reference is opposite or absence of 
that finding  
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Table 14. Multivariable regression models for amniotic fluid index (AFI), against: i. 
symphysis-fundal height (SFH); ii. uterine fundal ballottability; iii. presenting part (PP) 
ballottability; and iv. a composite of no fundal and no PP ballottability and SFH<39 cm; 
in each case adjusting for gestational age (GA) and HIV status (n=100). 
 Beta co-
efficient 
 
Standard 
error 
95% CI P value 
i. SFH:* 
GA in weeks 
HIV infected 
Symphysis-fundal height in cm 
 
 
-0.84 
-1.96 
0.36 
 
0.26 
1.00 
0.15 
 
-1.37; -0.32 
-3.95; 0.24 
0.06; 0.66 
 
<0.01 
0.05 
0.02 
ii. Fundal ballottability:† 
GA in weeks 
HIV infected 
Fundal parts not ballottable 
 
 
-0.61 
-2.29 
-2.42 
 
0.27 
0.99 
0.94 
 
-1.15; -0.07 
-4.26; -0.32 
-4.29; -0.55 
 
0.03 
0.02 
0.01 
iii. PP ballottability:‡ 
GA in weeks 
HIV infected  
Presenting part not ballottable 
 
 
-0.68 
-2.28 
-2.30 
 
0.27 
0.99 
0.84 
 
-1.21; -0.16 
-4,24; -0.31 
-3.86; -0.53 
 
0.01 
0.02 
0.01 
iv. Composite of SFH and ballottability:§ 
GA in weeks 
HIV infected  
Composite of SFH and no ballottability 
 
 
-0.75 
-2.14 
-2.64 
 
0.26 
0.97 
0.77 
 
-1.26; -0.24 
-4.06; -0.22 
-4,17; -1.10 
 
 
<0.01 
0.03 
<0.01 
Equations: 
*AFI = 28.48 – 0.84 (GA in weeks) – 1.96 (HIV infected) + 0.36 (SFH in cm); R2 = 0.19.  
†AFI = 34.77 – 0.61 (GA in weeks) – 2.29 (HIV infected) – 2.42 (fundal non-ballottability); R2 = 
0.19. 
‡AFI = 37.22 – 0.68 (GA in weeks) – 2.28 (HIV infected) – 2.20 (PP non-ballottability); R2 = 0.20. 
§AFI = 39.56 – 0.75 (GA in weeks) – 2.14 (HIV infected) – 2.64 (composite); R2 = 0.23. 
 
Tests were performed for model assumptions in the four multivariable linear regression 
models shown in Table 14. The assumptions of linearity, approximately normal distribution 
of y-residuals, homoskedasticity, and the influence of outliers using dfbeta plots with 
sensitivity analysis, provided reassurance of the appropriateness and applicability of the 
models (Appendix E).  
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The association of each of the measurements and clinical signs with the binary outcome of 
oligohydramnios (AFI <5 cm) was investigated using univariable logistic regression (Table 
15). In this analysis, only presenting part ballottability was associated with oligohydramnios.    
 
Table 15. Comparison of clinical signs for amniotic fluid volume on abdominal and 
vaginal examination, in women with oligohydramnios (amniotic fluid index <5 cm) and 
normal amniotic fluid volume (amniotic fluid index ≥5 cm), by univariable logistic 
regression (n=100). 
Explanatory variable Oligo-
hydramnios 
(n=23) 
 
Normal AFV 
(n=77) 
Odds ratio (95% 
CI)  
P value 
Mean symphysis-fundal height 
(cm) 
 
37.4 ± 3.0 38.0 ± 2.5 0.91 (0.76; 1.10) 0.34 
Mean abdominal 
circumference (cm) 
 
103.4 ± 7.9 101.5 ± 6.4 1.04 (0.97; 1.12) 0.22 
Head five fifths palpable 
(n=99)* 
 
 
11 (50%) 
 
44 (57%) 
 
0.69 (0.27; 1.75) 0.43 
Uterine irritability† 
 
 
7 (30%) 21 (27%) 1.17 (0.42; 3.24) 0.77 
Parts not ballottable in uterine 
fundus† 
 
19 (83%) 56 (73%) 1.78 (0.54; 5.85) 0.34 
Presenting part not ballottable† 
 
 
20 (87%) 46 (60%) 4.49 (1.23; 16.42) 0.02 
Fetal compaction† 
 
 
3 (13%) 10 (13%) 1.00 (0.25; 4.01) 0.99 
Fetal parts easy to feel† 
 
 
12 (52%) 47 (61%) 0.70 (0.27; 1.78) 0.45 
Failure to elicit uterine 
fluctuance† 
 
5 (22%) 13 (17%) 1.37 (0.43; 4.35) 0.60 
Binary explanatory variables:  
*reference is head four fifths or less; †reference is opposite finding of that given in table  
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Presenting part ballottability was then placed in a multivariable logistic regression model 
alongside the significant predictors (gestational age and HIV status) obtained from the 
analyses shown in Tables 11 and 12. Presenting part ballottability remained a statistically 
significant predictor after adjustment for gestational age and HIV status (Table 16). Again, as 
for Table 12, removal of HIV status from the model with gestational age showed no 
statistically significant difference using the likelihood ratio test, but HIV status was retained 
because of its clinical significance. The data here show that the odds of oligohydramnios 
increase by a factor of 4.58 (95% CI 1.13-18.5) if the presenting part is not ballottable, as 
opposed to it being ballottable, after adjustment for gestational age and HIV status.   
Table 16. Multivariable logistic regression model for AFI <5 cm, against presenting part 
ballottability, adjusting for gestational age and HIV status (n=100). 
Explanatory variable Adjusted 
odds ratio 
Standard 
error 
 
95% CI  P value 
Gestational age in weeks 
 
 
1.77 0.48 1.04; 3.01 0.04 
HIV infected (reference HIV 
negative) 
 
2.81 1.64 0.89; 8.80 0.08 
Presenting part not 
ballottable (reference 
ballottable) 
 
4.58 3.27 1.13; 18.58 0.03 
 
5.6. Predictive ability of clinical palpation for oligohydramnios 
Presenting part non-ballottability had a sensitivity of 87% for oligohydramnios, with a 
specificity of 40%, and a positive likelihood ratio of 1.46 (Table 17). The receiver-operator 
characteristic (ROC) curve showed an area under the curve of 0.64 (Figure 2). After adjust-
ment for gestational age and HIV, presenting part non-ballottability showed an area under the 
curve of 0.76 in a receiver operator characteristic curve for oligohydramnios (Figure 3).    
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It is known from clinical experience that ballottability of the presenting part is only rarely 
elicited with a fetal head below five fifths palpable above the pelvic brim. Therefore, a 
similar calculation was made including only women where the presenting part was five fifths 
palpable (n=55). The sensitivity of non-ballottability was 73% with a specificity of 64% and 
a positive likelihood ratio of 1.96 for oligohydramnios (p=0.04) (Table 18).     
Table 17. Predictive value of presenting part ballottability for oligohydramnios 
(amniotic fluid index <5 cm) (n=100) 
 Oligo-
hydramnios  
 
Normal  AFV Totals 
Presenting part not ballottable 
 
20 46 66 
Presenting part ballottable 
 
3 31 34 
Totals 
 
23 77 100 
Sensitivity = 87%, specificity = 40%, positive predictive value = 30%, negative predictive value = 
91%, positive likelihood ratio = 1.46, negative likelihood ratio = 0.32. 
 
 
Figure 2. Receiver-operator characteristic curve for presenting part non-ballottability 
for oligohydramnios (amniotic fluid index <5 cm)  
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Figure 3. Receiver-operator characteristic (ROC) curve for presenting part non-
ballottability adjusted for gestational age and HIV infection, for oligohydramnios 
(amniotic fluid index <5 cm), derived from logistic regression model.  
 
 
 
 Table 18. Predictive value of presenting part ballottability for oligohydramnios 
(amniotic fluid index <5 cm) if fetal head five fifths palpable above the pelvic brim 
(n=55). 
 Oligo-
hydramnios  
 
Normal  AFV Totals 
Presenting part not ballottable 
 
8 16 24 
Presenting part ballottable 
 
3 28 31 
Totals 
 
11 44 55 
Sensitivity = 73%, specificity = 64%, positive predictive value = 33%, negative predictive value = 
90%, positive likelihood ratio = 1.96, negative likelihood ratio = 0.43. 
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6. DISCUSSION 
6.1. Maternal, fetal and obstetric characteristics and outcomes 
The mean and range of gestational age of women referred for suspected prolonged gestation 
reflected the uncertainty of MOU midwives in making decisions based on gestational age. 
The approximately normal distribution of AFIs is suggestive of a term, rather than post-term 
population of pregnancies. One should expect post-term pregnancies to show a positively 
(left) skewed distribution of AFIs, with values clustered towards low AFI measurements. 
Less than half of the 100 referred women had a best estimate gestational age ≥41 weeks. In 
retrospect, therefore, more than half of these women need not have been referred, since the 
information used by the researcher to determine gestational age was also available to the 
referring midwives. Only 26 women had gestational age information from early ultrasound 
scans, and in 16 of these, the gestational age was ≤41 weeks, yet even those 16 women were 
referred. These findings will back up efforts to improve antenatal care and referral. In-service 
training and triage clinics with experienced midwives could be introduced, to reduce 
unnecessary referrals and anxiety for pregnant women.  
The neonatal outcomes were good in this small series of 100 pregnancies, with no deaths and 
no serious morbidity. A limitation of this study was the absence of detailed intrapartum 
information such as length of labour, intrapartum fetal heart rate abnormalities and 
meconium-staining of the AF. The caesarean section rate of 46% for labour inductions was 
high, even higher than the 38% recently reported for inductions of labour for prolonged 
pregnancy in a teaching hospital in Cape Town.
96
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6.2. Amniotic fluid index related to maternal and fetal factors 
The statistically significant inverse association between gestational age and AFI was 
expected, showing similar results to previous work.
24,34
 The frequency of AFI <5 cm was 
much higher than in most studies that measured AFI at advanced gestations,
28,34
 but similar to 
findings by Phelan et al. for pregnancies ≥41 weeks.23 It must however be remembered that in 
this study less than half of the women were estimated to be ≥41 weeks pregnant. The 
ultrasonographer showed good intra-observer variability, although the women were re-
measured immediately after their first measurement, making it likely that the ultrasono-
grapher would sample the same AF pockets, and make very similar measurements.  
The association between HIV infection and AFI was a surprise. No hypothesis on HIV had 
been proposed and the variable was included only as an essential clinical factor, along with 
parity, height, weight and others. A literature search for an association between HIV and 
oligohydramnios did not reveal any similar results. Low birth weight has been associated 
with HIV infection,
97
 and if this is related to placental insufficiency, the association with 
oligohydramnios can be explained. But if so, the mechanism through which HIV infection 
may result in placental insufficiency is not known, although chronic inflammation could play 
a role. A possible explanation may be found in the HAART drug regimen, which includes 
tenofovir, known to be nephrotoxic in adults.
98
 One could speculate on whether the tenofovir 
reduced fetal urine output, but that, and the role of HIV in oligohydramnios, needs to be the 
subject of further research.   
The association of gestational age and HIV with AFI, both remaining in adjusted statistical 
models, and the absence of influence of any of the other maternal and fetal factors, meant that 
gestational age and HIV were included as factors for adjustment in assessing the role of 
clinical palpation for AFI.  
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6.3. Clinical palpation for amniotic fluid volume 
The general impressions of AFV, given by the researcher and by the colleagues, were no 
better than chance in predicting oligohydramnios as defined by an AFI <5 cm. Also, the 
researcher’s and the colleagues’ findings on the same women showed no agreement using the 
kappa test. This method of AFV estimation was similar to that described in the studies by 
Barnes et al. and Crowley at al.
7,8
 In terms of sensitivities and specificities, the findings were 
very similar to those of Barnes et al., suggesting likelihood ratios close to 1, equivalent to a 
useless test. The findings cannot be compared directly with those of Crowley et al., who used 
clinical outcomes (meconium-stained AF and absent AF at delivery) as their endpoint. The 
lack of agreement between the researcher and the clinician colleagues cannot be explained by 
the data, but it is possible that different clinicians do not use uniform methods for estimating 
AFV. One might find better agreement in a study where specific aspects of AFV estimation, 
e.g. ballottability, are examined for inter-observer variability. 
This study showed, by separate evaluation of different elements of palpation, that ability to 
ballot fetal parts was predictive for AFI, as previously suggested, without evidence from 
research, in a number of texts.
3,4
 In the hands of the researcher, ease of palpation of fetal 
parts, and the impression of a fetus cramped for space,
3,6
 did not correlate well with 
oligohydramnios. The researcher’s own ideas, that uterine fluctuance or uterine irritability 
could perhaps predict AFI, were also not borne out. Ballottability, both in the fundus and of 
the presenting part, remained predictive for AFI after adjustment for gestational age and HIV. 
When oligohydramnios was the endpoint, only presenting part ballottability, generally 
associated with a head at five-fifths above the brim, was significantly associated, both in 
crude and adjusted analysis. It should be noted that ballottability refers to back-and-forth 
movement of parts felt inside the uterus, not back-and-forth movement of the uterus in the 
abdominal cavity.  SFH was also associated with AFI, as suggested in the Myles midwifery 
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textbook, where reference was made to ‘small-for-dates’ uterus in prediction of oligo-
hydramnios.
3
 The composite of fundal ballottability, presenting part ballottability and 
reduced SFH provided a better co-efficient of determination (R
2
=0.23) for AFV than each of 
the measures on their own, although the coefficient did not differ much from that found with 
each of the measures individually.   
6.4. Predictive ability of presenting part ballottability for oligohydramnios 
This study sought a simple clinical method, not for estimating AFV, but for identifying 
oligohydramnios as part of screening for fetal well-being in suspected prolonged pregnancy. 
The one promising physical sign was presenting part ballottability, as shown by its sensitivity 
and specificity and performance on ROC curves, both unadjusted, and adjusted, for 
gestational age and HIV. The positive likelihood ratio improved to 2.0 when women with 
fetal heads not five-fifths palpable were excluded, but this reduced the applicability of the test 
to only about half of the study population. The most important finding was in the negative 
predictive value of 90%, irrespective of the level of the head. The practical significance is as 
follows. If a woman from this community presents with a suspected prolonged pregnancy and 
the presenting part can be ballotted in the uterus, there is a 90% probability of finding an AFI 
≥5 cm. While this may sound impressive, the fact remains that even without palpating the 
uterus at all, there is a 77% probability that a randomly selected woman from this study has 
an AFI ≥5 cm. Negative predictive value is dependent on prevalence of a condition in a 
community, and therefore the 90% finding can only be generalized to pregnant populations 
similar to the one studied here.  
Presenting part ballottability is only a weak predictor of oligohydramnios, and can probably 
not replace ultrasound scanning if AFV is to be a part of assessment of women with 
suspected prolonged pregnancy. Where, however, there is no ultrasound facility for AFI 
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assessment, presenting part ballottability could be used to obtain reassurance about AFV in 
pregnancies suspected to be prolonged.  
6.5. Limitations 
A number of limitations must be acknowledged. The women recruited for the study was a 
sample determined by whoever arrived earliest at the antenatal clinic. This study was 
primarily designed to investigate clinical palpation to predict oligohydramnios, and was not 
intended as an epidemiological study of prolonged or post-term pregnancy in the Chris Hani 
Baragwanath referral area. Therefore, the maternal, fetal and obstetric characteristics of this 
group of women should not be assumed to represent all women in this area with suspected 
prolonged pregnancy. It is not known if the women arriving early could have been a selected 
subgroup of prolonged pregnancies, for example where there was greater concern about the 
pregnancy. No data is available for women who arrived later at the antenatal clinic.  
The sample size of 100, based on clinical experience from work at the hospital, was adequate 
for demonstrating an association between abdominal palpation and oligohydramnios, but left 
little room for analysis of subgroups, such as only those women who were considered to be 
≥41 weeks pregnant, and the influence of multiple covariates. The association between 
oligohydramnios and HIV, for example, could have been better defined using a larger sample. 
Any further research, whether on presenting part ballottability, or on HIV and AFV, can 
make use of the findings in this study for its sample size calculations.   
A valid criticism would be the use of AFI as a gold standard for AFV. Dye-dilution or direct 
measurement of AF at caesarean section or hysterotomy are the current gold standards. Dye 
dilution would have presented ethical problems because of the need for non-essential 
amniocentesis. An ultrasound scan followed immediately by caesarean section and AF 
collection would have been possible in theory, but was not a practical option. AFI remains 
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the best non-invasive measure, with reasonable correlation, for AFV.
38,40-42
  AFI has been 
used as a gold standard in at least one published study, on transcervical ultrasound estimation 
of AFV.
48
      
The elements of palpation for AFV, such as presenting part ballottement, were performed by 
a single researcher, with no evaluation of intra-observer variability, or even of inter-observer 
variability by asking the colleagues to repeat the elements of palpation. The CHBAH 
antenatal clinic is just too busy to allow for this type of distraction, which would have 
inconvenienced other women waiting to be consulted. It was considered sufficient and not too 
time-consuming just to ask the colleagues if they considered AFV to be normal or reduced, as 
was done in the study by Barnes et al.
7
 If a study is ever done to validate presenting part 
ballottement, then the consultant colleagues could be asked only to feel for this clinical sign, 
again without wasting too much time on multiple different palpation methods.  
The blinding process made it impossible for the researcher or the colleagues to know the 
gestational age or the AFV before palpating each woman’s abdomen. This was the strength of 
the study. What was impossible to blind was the initial finding on first abdominal palpation. 
Whatever impression was gained at that point may have influenced subsequent systematic 
palpation. For example, if the first feel of the abdomen suggested reduced AF, then the 
researcher might have decided that ballottability was absent or fetal parts were easily felt, 
based on preconceptions or textbook knowledge. Such information bias, if it occurred, would 
have biased the systematic palpation findings, such as presenting part ballottability, towards 
the null, in view of the negative eventual result of general impression on palpation, thus 
favouring a type II rather than a type I statistical error.  
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6.6. Conclusion 
To the best of the researcher’s knowledge, this is the first study to show which of the 
elements of clinical abdominal palpation are able, and which are unable, to predict AFV at 
and beyond term. The ability to ballot fetal parts, as suggested in some textbooks, can predict 
AFV. The study has also dismissed the composite guess of AFV on general abdominal 
palpation as little more than useless. 
In terms of the practical application of clinical palpation for AFV in prolonged pregnancy, 
the study offered mixed results. Although presenting part ballottability was significantly 
inversely related to reduced AFI (oligohydamnios), the test characteristics (sensitivity, 
specificity, positive likelihood ratio) were too weak to allow such palpation to dictate clinical 
management. If AFV needs to be measured as part of management of suspected prolonged 
pregnancy, ultrasound scanning remains the method of choice. One should only venture a 
prediction of AFV based on ballottability of the presenting part if ultrasound scanning is 
unavailable. In such circumstances, ballottability increases the probability of the AFV being 
normal, and may assist in the clinical decision to admit a woman for induction or to continue 
with pregnancy surveillance.  
Further research should focus on the significance of ballottability, using a larger sample size, 
based on this study’s findings, and a more refined hypothesis. The predictive value of this 
clinical sign needs to be tested in a group of obstetric clinicians and midwives, standardizing 
the method and testing also for intra- and inter-observer repeatability. Favourable results 
would allow use of this simple method of palpation to assist clinical decision-making in cases 
of suspected prolonged pregnancy where ultrasound is unavailable.   
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Appendix A: Ultrasound form 
Postdates pregnancy: ultrasound assessment 
Name...........................................................        Date.............................. 
 
BPD ........................... = .......................... weeks 
 
FL .............................. = .......................... weeks 
 
AC ............................. = .......................... weeks 
 
FH ........      Other ...................................................................................... 
 
AFI 1: 
 
 
 
 
 
Please repeat AFI if AFI1 is less than 10 cm 
 
AFI 2: 
  
Left upper 
Left upper 
AFI 1 = .................................. cm 
AFI 2 = .................................. cm 
EFW ..............................  g 
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Appendix B: Data sheet  
Date...........................     Study no.………….      Age………… Parity…………   Prev CS……… 
Gestation (LMP)……..…Best gestation…..….. by early scan(1), dates(2), late scan(3), other (4)…….. 
Public scan................ Private scan....................      
Smoking ……  Per day........  HPT .........  HIV …...  CD4 …….  HAART…....  Weight…......… kg  
Height………. cm MUAC............cm    AC…………. cm            SFH……… cm  
Head in fifths…….....  Irritability ……… 
Fundal ballottement……………………. 
Suprapubic ballottement……………….. 
Fetus free................................................. 
Fetal parts obscured..........……………… 
Uterine compressibility.………………… 
Cervical forewaters….………………….. 
General impression……………………… Colleague impression..............   Rank............ (1,2) 
Cervix (Bishop): 
Dilatation……………=………….   Length………………=…………. 
Consistency…………=………….   Position………………=………… 
Station………………=………….    TOTAL....................... 
 
MVP1…………. MVP2..............              MVP..................... cm      
AFI1………......  AFI2……...…..     AFI........................cm 
      EFW..................................... g 
 
Labour spontaneous……….   Date of birth..............................   Interval ...................    Hospital........... 
Caesarean section………………            Birthweight……………………. g  Indication.............. 
Stillbirth……………………….. 5-minute Apgar………………….. 
Neonatal admission…………….. Neonatal death………………  
Admitted for IOL................  
0  1  2  3                                                                               
Dil  0 1-2 3-4 5                                                                    
Length        5 3-4 1-2 0                                                            
Cons            Firm Med Soft                                                              
Pos              Post Mid Ant                                                            
Stat -3 -2 -1,0 +1 
 
1 = CPD/poor progress                                         
2= Fetal distress                                               
3=Failed IOL                                                   
4=Elective CS                                                
5=Other 
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Appendix C: Information and consent form 
Information and consent form 
GOOD DAY. My name is Dr Eckhart Buchmann. I am a specialist obstetrician doctor working at 
Chris Hani Baragwanath Hospital. I am doing a research project to achieve a master’s degree (MSc) 
with Wits University. I am inviting you to participate in this project because you were referred by 
your clinic because your pregnancy seems to have gone past its expected dates.  This form has 
information to help you decide if you want to take part. Read it carefully and feel free to ask me or 
any staff member for assistance.  
What is the project about? 
We have a problem with women whose pregnancies have gone (or are thought to have gone) past their 
expected delivery dates. This can be dangerous for the unborn baby because 1) the baby may be big, 
and 2) the baby may have a shortage of water (amniotic fluid) around it, allowing the baby’s umbilical 
cord to be squeezed, and also allowing the baby’s faeces (meconium) to become very thick if the baby 
passes faeces in the womb.  
Research has found that if we do a sonar (ultrasound scan) in women who have gone past their 
expected delivery dates, we can find out which babies have enough water around them and should be 
safe, and which babies don’t and could be in danger. Those in danger can be admitted to hospital for 
us to induce labour and monitor the baby’s condition during labour.  The problem in many places (not 
here) is that there is not always sonar available to measure the amount of water around the baby. My 
research will try to find out if a doctor (me) can estimate the amount of water in the womb by feeling 
women’s tummies without doing a sonar but you will be sent for a sonar anyway because that is the 
way we measure the water around the bay at this time. 
Why have I been chosen to participate?  
You have been chosen because you have been sent by your clinic to the hospital, for the reason that 
the clinic sisters think that your pregnancy might have gone past its expected delivery date. We at the 
hospital need to see if we agree that your pregnancy has gone past its expected delivery data, and we 
need to find out if your baby is safe or in danger.  
What exactly will be done to me? 
 I will examine you and do all the tests that are necessary to determine whether you more than 41 
weeks and send you for a sonar. I will take information from your card, and I will then feel your 
tummy and try to work out if there is enough water around your baby. I will also feel in your vagina if 
your womb is open or not so that we can decide whether or how we should induce labour, and how 
much water I can feel Then you will have a sonar done to measure the amount of water around the 
baby. I will write down all this information on a special form. Your name and hospital number will 
not be written on the form. All of these examinations and sonar are part of the normal care that you 
would have got in pregnancy, except for the findings from my feeling your tummy for water.  After 
having the sonar, one of our specialist doctors or me will talk with you about what we found, and 
decide on how to treat your pregnancy further. Your treatment has nothing to do with my research. 
We will not use the finding from my examination to decide how to treat you. But we will use the 
sonar findings.   
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Do I gain by participating in this project? 
You do not gain directly. What I am doing will not affect the way you are treated. This is a research 
project where we want to find out how to improve care of women like you in the future. The 
measurements that I get from feeling your tummy will not be used to treat you, and will not be known 
to nurses and doctors treating you. Also, you will not receive any reward for agreeing to participate in 
this project. 
Will there be any harm to my baby or me if I participate? 
Feeling your tummy and making my findings will not harm you or your baby in any way, as the 
information from that will not be used to treat you. Whether or not you take part in this research 
project, I have to tell you that there can be problems with the pregnancy or birth. So, I cannot promise 
that you or your baby will be fine during the pregnancy or during labour or after birth.  
Could the information obtained in my file end up in the wrong hands?  
No. Everything I find out about you is strictly confidential. All the information will go on to my 
special form that will not have your name or hospital number on. The form contains only a study 
number and I will be the only person who knows that the study number is yours.  
What will happen if I do not want to participate?  
You are free to refuse to take part in the project. It will not affect the way you are treated by nurses 
and doctors here. Even if you sign the consent form to participate, and you change your mind later, 
you may withdraw from the project. That is your decision and I will respect that. 
Who can I speak to if I have a question regarding the research? 
If you have any questions about the research, you may ask the doctor or nurse who is attending to you 
in the hospital, or you can speak to me directly on 0834087777 or 0119338155 or 0119338156, even 
after you have left the hospital. This research has also been approved by the University of the 
Witwatersrand’s Human Research and Ethics Committee. If you have any queries about whether this 
study is safe or allowed to be done, you may call the committee’s secretary, Ms Anisa Keshav, at 
0117171234 during working hours. 
Consent  
I agree to participate in this project. Dr Buchmann will take information from my card, feel my 
tummy, do a vaginal/internal examination, write down the sonar findings and write down what 
happened to me and my baby.  
The forms he uses in this project will not include my name or hospital number. I understand that I am 
not entitled to any gain for me taking part in the project. I also understand that I may withdraw my 
consent for participation at any time, even after I have signed this form.  
 
Participant....................................................     Witness.............................................. 
 
 
Researcher....................................................     Date...................................................  
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Appendix D: HREC approval 
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Appendix E: 
Linear regression diagnostics for amniotic fluid index for the model containing the 
predictors of gestational age, HIV infection and presenting part ballottability.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Tests for assumptions in multiple linear regression with AFI as the outcome, 
and gestational age, hiv status positive, and presenting part ballottability as the 
exposure variables: a) linearity assumption:....; b) normal distribution of residuals....; c) 
RVF (residual v. fitted) plot to confirm homoskedasticity; Cook-Weisberg test; p=0.61; 
d) residual v. plotted (RVP) plot for variance of residuals for gestational age.    
Outlier = woman with AFI of 22 cm – not removed from analysis 
Also did tables for hiv and ppballot residuals, and did dfbetas with sensitivity analysis 
for 0.2 and 0.4 – results essentially the same. 
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